Cardiometabolic Research Advances Using GLP-1 Receptor Therapy

Find out about GLP-1 receptor therapy on cardiometabolic health and its revolutionary role in modern medicine and patient care.

Abstract

Hello, I’m Dr. Alex Jimenez, and I am honored to share transformative insights into managing cardiovascular and metabolic conditions, such as type 2 diabetes. This educational post explores a significant shift in our medical understanding, moving from a purely glucose-centric model to a comprehensive, risk-reduction strategy. Here, we will journey through the latest findings from leading researchers, backed by robust, evidence-based studies, to understand this new paradigm. We’ll delve into the mechanisms of two groundbreaking classes of medications—SGLT2 inhibitors and GLP-1 receptor agonists—and their profound benefits for cardiovascular and renal health, often independent of their glucose-lowering effects. We will also discuss how our multidisciplinary team at Injury Medical Clinic PA, including the invaluable medical direction of Dr. Maria Guadalupe Cardenas, MD, integrates these advancements with integrative chiropractic care, functional medicine, and rehabilitation to provide a truly holistic treatment plan for our patients in El Paso, Texas. This post aims to illuminate the interconnectedness of cardiac, metabolic, and kidney health and present a collaborative path forward for optimal patient outcomes.

Our Collaborative and Integrative Practice at Injury Medical Clinic PA

Before we delve into the clinical science, I want to take a moment to explain our unique approach to patient care here in El Paso, Texas. At Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, we have built a truly multidisciplinary practice. I am Dr. Alex Jimenez, and my credentials include DC, APRN, FNP-BC, CFMP, IFMCP, ATN, and CCST. My passion lies in functional medicine and chiropractic care, focusing on the body’s innate ability to heal and the musculoskeletal system’s foundational role in overall health.
A cornerstone of this model is my collaboration with Dr. Maria Guadalupe Cardenas, MD. With over 40 years of experience as a board-certified internist, Dr. Cardenas serves as our Medical Director and Collaborative Physician (NPI #1164426749, Texas MD License #J2933). Her extensive expertise in internal medicine provides essential medical oversight and direction, allowing us to seamlessly merge advanced medical protocols with chiropractic, functional medicine, rehabilitation, and personal injury care.
Our model is built on the synergy between different disciplines:

Medical Oversight (Dr. Cardenas): Provides diagnoses, prescribes medications like the advanced therapies we will discuss today, and oversees the overall medical treatment plan, ensuring patient safety and efficacy.
Chiropractic and Functional Medicine (Dr. Jimenez): I focus on identifying and addressing the root causes of dysfunction. Through chiropractic adjustments, we restore proper nerve function and biomechanics. With functional medicine, we analyze a patient’s genetics, lifestyle, and environment to correct underlying imbalances in metabolism, inflammation, and gut health.
Integrated Services: Together, we manage personal injury cases, rehabilitation, nutritional counseling, and chronic disease management. This team-based approach ensures that a patient with diabetes, for example, not only receives the latest medications but also benefits from dietary overhauls, targeted supplementation, and structural care to improve insulin sensitivity and reduce systemic inflammation. This is the essence of integrative medicine—uniting the best of multiple worlds for superior patient outcomes.

The Critical Link Between Diabetes and Cardiovascular Disease

For a long time, the primary focus in managing type 2 diabetes was on lowering blood glucose. While important, this approach was incomplete. We now have an overwhelming body of evidence showing that people with diabetes face a significantly elevated risk for Atherosclerotic Cardiovascular Disease (ASCVD), which includes coronary heart disease, stroke, and peripheral arterial disease. In fact, ASCVD is the leading cause of death for individuals with diabetes.

Consider this startling fact: over 70% of individuals with diabetes over the age of 65 will likely succumb to heart disease or a stroke.
Following a heart attack (myocardial infarction or MI), people with diabetes have a much higher mortality risk and a poorer long-term prognosis.
These grim outcomes persist even when blood sugar levels are well-controlled, and they affect individuals with both type 1 and type 2 diabetes.

This reality has forced a paradigm shift in how we manage these interconnected conditions. The focus has expanded from aggressive glucose reduction to a holistic strategy to reduce overall cardiovascular and renal risk. This involves managing not just blood sugar, but also blood pressure, cholesterol levels, weight, physical activity, and smoking cessation. For the first time in my career, all the major guideline-issuing bodies—including the American College of Cardiology (ACC), the American Heart Association (AHA), the American Diabetes Association (ADA), and the Kidney Disease: Improving Global Outcomes (KDIGO)—are in complete agreement on this new, integrated approach to care. This consensus marks a monumental step forward, allowing us to view and treat our patients through a unified, comprehensive lens.

Rethinking Treatment Algorithms: A Risk-Based Approach

This new paradigm is reflected in the latest treatment algorithms from the American Diabetes Association. The guidelines now emphasize a risk-stratified approach. For any patient with type 2 diabetes who has established ASCVD, heart failure, chronic kidney disease (CKD), or is at high risk for developing these conditions, the recommendation is to concurrently address all risk factors and prioritize specific classes of medications.
The algorithm directs us to move beyond traditional first-line agents like metformin alone and immediately consider two powerful classes of drugs:

SGLT2 (Sodium-Glucose Cotransporter-2) Inhibitors
GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists

These medications are now recommended as foundational therapies for high-risk patients precisely because they have demonstrated proven cardiovascular (CV) benefits in large-scale clinical trials. The choice between them, or the decision to use them in combination, depends on patient-specific factors, comorbidities, and preferences. This marks a significant departure from simply trying to lower the A1C; it’s about proactively protecting the heart and kidneys.

The History and Evolution of Diabetes Medication Trials

How did we arrive at this pivotal moment? The story begins around 2008, when the U.S. Food and Drug Administration (FDA) issued mandatory guidance for all new antidiabetic medications. The FDA required pharmaceutical companies to conduct long-term Cardiovascular Outcomes Trials (CVOTs). The primary goal was to ensure that these new drugs did not increase the risk of Major Adverse Cardiovascular Events (MACE)—a composite of non-fatal heart attack, non-fatal stroke, and cardiovascular death.
This mandate was a direct response to past experiences where certain drugs, such as rosiglitazone (Avandia) and others like Vioxx, were later found to cause cardiovascular harm. Earlier studies were often too short, underpowered, or poorly designed to detect these risks. The FDA’s new requirement forced the industry to conduct large, well-designed, placebo-controlled trials that were robust enough to demonstrate safety or non-inferiority.
What happened next was truly surprising. As the results of these CVOTs began to be published, starting with the EMPA-REG OUTCOME trial for empagliflozin (Jardiance) in 2015, researchers discovered something extraordinary. These new drugs weren’t just safe—some of them were actively protective.

Empagliflozin (Jardiance), an SGLT2 inhibitor, was the first to show a significant reduction in MACE, CV death, and hospitalization for heart failure.
Liraglutide (Victoza), a GLP-1 receptor agonist, followed in 2016 with the LEADER trial, also demonstrating significant cardiovascular benefits.

These unexpected findings of superiority, not just safety, were game-changers. They provided the evidence needed to completely overhaul the clinical guidelines and place these drug classes at the forefront of managing patients with cardiovascular, metabolic, and renal disease.

A Deeper Dive into SGLT2 Inhibitors

Let’s explore the SGLT2 inhibitor class more closely. These medications work by blocking glucose reabsorption in the kidney, causing excess sugar to be excreted in the urine. While this helps lower blood glucose, their profound cardiovascular and renal benefits appear to stem from multiple other mechanisms.

Landmark Cardiovascular Outcomes Trials for SGLT2 Inhibitors

Several major CVOTs have established the benefits of this class:

EMPA-REG OUTCOME (empagliflozin/Jardiance): This trial was a watershed moment. It showed a highly statistically significant reduction in MACE, CV death, and hospitalization for heart failure.
CANVAS Program (canagliflozin/Invokana): Demonstrated significant reductions in MACE and hospitalization for heart failure.
DECLARE-TIMI 58 (dapagliflozin/Farxiga): While it didn’t show a significant reduction in MACE, it showed a substantial and statistically significant reduction in the risk of hospitalization for heart failure.
VERTIS-CV (ertugliflozin/Steglatro): Also showed a significant reduction in hospitalization for heart failure risk (a 30% relative risk reduction).

The consistent and powerful effect on reducing hospitalizations for heart failure across the class is particularly noteworthy and has led to their widespread adoption in cardiology.

The Multifaceted Mechanisms of SGLT2 Inhibitors

What makes these drugs so effective? The benefits go far beyond simple glucose lowering. Some of the proposed mechanisms that contribute to their cardioprotective and renoprotective effects:

Hemodynamic Effects: SGLT2 inhibitors have a mild diuretic effect, which helps reduce blood pressure by about 3-5 mmHg systolic. This is achieved through natriuresis, or the excretion of sodium and water, which reduces fluid volume and preload on the heart.
Reduced Glomerular Pressure: In the kidneys, these drugs reduce pressure within the glomerulus (the kidney’s filtering unit). This is a key theorized mechanism for their nephroprotective (kidney-protecting) effects, slowing the progression of diabetic kidney disease.
Metabolic Shifts: SGLT2 inhibitors promote a slight shift towards ketosis. The heart is a unique metabolic organ that can efficiently use ketones as a fuel source. This “super fuel” improves myocardial efficiency and function, especially in a stressed or failing heart.
Systemic Benefits: They also contribute to a modest weight loss (around 5-7 pounds), reduce inflammation, decrease oxidative stress, and may improve endothelial function and stabilize atherosclerotic plaques.
Improved Myocardial Energetics: By reducing the workload on the heart (via lower blood pressure and volume) and providing a more efficient fuel source (ketones), these drugs improve the overall energy balance and function of the heart muscle.

SGLT2 Inhibitors in Heart Failure and Kidney Disease

The benefits of SGLT2 inhibitors have been so profound that their use has expanded to patients without diabetes.

Heart Failure Trials

DAPA-HF and EMPEROR-Reduced: These trials studied dapagliflozin and empagliflozin, respectively, in patients with heart failure with reduced ejection fraction (HFrEF). Both showed a remarkable 25-26% relative risk reduction in the composite outcome of cardiovascular death or hospitalization for heart failure, regardless of whether the patients had diabetes.
EMPEROR-Preserved: This was the first trial to show a meaningful benefit in patients with heart failure with preserved ejection fraction (HFpEF), a very common and difficult-to-treat type of heart failure, particularly in older adults, women, and those with obesity. Empagliflozin reduced the primary composite endpoint by 21%.

Kidney Disease Trials

The evidence for kidney protection is just as compelling:

DAPA-CKD (dapagliflozin): This trial was stopped early due to overwhelming efficacy. It showed a 39% reduction in the risk of progression of kidney disease.
EMPA-KIDNEY (empagliflozin): Also demonstrated a significant 28% reduction in the risk of kidney disease progression or cardiovascular death.
CREDENCE (canagliflozin): Showcased a 30% reduction in the risk of kidney failure and cardiovascular events in patients with type 2 diabetes and kidney disease.

These trials have firmly established SGLT2 inhibitors as a cornerstone therapy for chronic kidney disease, even in patients without diabetes.

Understanding the Incretin Effect: TheBody’ss Natural Glucose Response System

For years, the management of type 2 diabetes centered on a few key strategies. However, a fascinating discovery completely shifted our understanding and opened the door to a new class of powerful therapies. Researchers observed a peculiar phenomenon: when people consumed glucose orally (by drinking it), their bodies produced a much more robust insulin response to lower blood sugar than when the same amount of glucose was administered intravenously (IV). This observation led them to a logical conclusion: there must be something happening in the gut when food is ingested that signals the pancreas to ramp up insulin production.
This phenomenon was termed the “incretin effect.” The “somethings” responsible were identified as gut hormones called incretins, primarily glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).

The Process: When you eat, food travels to your stomach and intestines. Specialized cells in your gut (L-cells) detect the presence of nutrients and release GLP-1 and GIP into your bloodstream.
The Signal: These hormones then travel to the pancreas, where they act as messengers. They bind to receptors on pancreatic beta cells, stimulating the cells to release insulin.
The Result: This insulin release helps your body’s cells take up glucose, effectively lowering your blood sugar levels after a meal.

Crucially, this entire process is glucose-dependent. This means the incretins only stimulate insulin release when blood sugar levels are high, as they are after a meal. This built-in safety mechanism significantly reduces the risk of hypoglycemia (dangerously low blood sugar) when these pathways are targeted with medication, especially compared to older diabetes drugs.

The Blunted Incretin Effect in Type 2 Diabetes

One of the key physiological defects we see in patients with type 2 diabetes is a blunted or even absent incretin effect. Their bodies produce insufficient amounts of native GLP-1 in response to food. This deficiency contributes significantly to the hallmarks of the disease:

Poor Post-Meal Glucose Control: Without a strong incretin signal, the pancreas doesn’t release sufficient insulin after eating, resulting in prolonged periods of high blood sugar.
Dysregulated Appetite: Native GLP-1 also plays a critical role in promoting satiety, or the feeling of fullness. Low levels of this hormone can lead to a state of poor satiety, contributing to overeating and the obesity that is so often a comorbid condition with type 2 diabetes.
Excess Glucagon Secretion: GLP-1 normally helps suppress the release of another hormone called glucagon. Glucagon tells the liver to produce and release more sugar into the bloodstream (gluconeogenesis). In type 2 diabetes, this suppression is impaired, so the liver continues to release glucose even when blood glucose is already high.

Understanding this hormonal defect was the key that unlocked the development of GLP-1 receptor agonists—medications designed to mimic the action of our natural GLP-1 and restore these vital functions.

The Silent Threat: Hyperhomocysteinemia and its Impact on Your Health- Video

How GLP-1 Receptor Agonists Revolutionize Treatment

GLP-1 receptor agonists are a class of medications that bind to and activate GLP-1 receptors throughout the body, just as our native GLP-1 would, but they are engineered to last much longer. Their multifaceted mechanism of action addresses several core issues in type 2 diabetes and obesity simultaneously.

Stimulates Insulin Secretion: By activating pancreatic receptors, they prompt a glucose-dependent release of insulin, directly lowering blood sugar.
Inhibits Glucagon Secretion: They effectively tell the liver to stop producing excess sugar, which is a major contributor to high fasting and post-meal glucose levels.
Slows Gastric Emptying: This is a key mechanism for both glucose control and weight loss. By slowing down the rate at which food leaves the stomach, they prevent rapid spikes in blood sugar after meals. This delay also contributes to a prolonged feeling of fullness, which naturally leads to a decrease in overall food intake. This effect is often responsible for the common initial side effects like nausea, but it is also a primary driver of the medication’s success.
Increases Satiety: GLP-1 receptor agonists act directly on appetite centers in the brain, enhancing the feeling of fullness and reducing food cravings. This neurobiological effect is fundamental to the significant weight loss seen with these therapies.

Collectively, these actions lead to profound improvements in A1c, blood glucose, and body weight, tackling the metabolic dysfunction of type 2 diabetes at its source.

The Challenge of Over-Basalization: A Case Study

To truly understand the paradigm shift in diabetes care,let’ss consider a typical patient I might see in our clinic, whom we’ll call Tony. He represents a common challenge where adding a GLP-1 agonist is the superior strategy.

Patient Profile: Tony
Age: 62 years
Diagnosis: Type 2 Diabetes (11 years), Hyperlipidemia, Hypertension
Recent A1c: 8.2% (well above the target of <7.0%)
Kidney Health: Proteinuria (protein in the urine), an early sign of kidney damage.
Current Medications:
- Degludec (basal insulin): 65 units daily
- Metformin: 1000 mg twice daily
- An SGLT2 inhibitor daily
- A statin for cholesterol
An ARB for blood pressure
Physical Stats: Weight 220 lbs, Height 5’9 ” “, BMI 32.5 (classifies as obese)
Blood Sugar Patterns:
- Fasting Glucose (morning): 15050 mg/dL
- Postprandial Glucose (after meals/bedtime): 160-200 mg/dL

Tony’s case highlights a critical issue we call over-basalization. We’ve pushed his basal (long-acting) insulin dose to a high level, yet his A1c and post-meal sugars remain dangerously elevated. Research in pharmacokinetics reveals that once you exceed a certain dose of basal insulin, typically around 0.5 units per kilogram of body weight per day, you get diminishing returns. For Tony, who weighs 100 kg (220 lbs), this threshold is about 50 units. He is already on 65 units, pushing him past the point of modest glycemic effect and into the territory of significant side effects, primarily weight gain and a higher risk of hypoglycemia.
For a patient like Tony, the conventional next step might have been to add prandial (mealtime) insulin. While this can control post-meal spikes, it comes with a heavy price: a near-certainty of further weight gain and a significantly increased risk of hypoglycemia. Given his BMI of 32.5, adding more weight would only worsen his insulin resistance, creating a vicious cycle.
This is where the 2024 guidelines from the American Diabetes Association (ADA) strongly recommend adding a GLP-1 receptor agonist. It addresses multiple problems at once, moving beyond simple glucose lowering, weight loss, and cardiovascular protection, which are crucial for a high-risk patient like Tony.

Beyond Blood Sugar: The Cardiovascular and Renal Benefits of GLP-1s

Perhaps the most exciting development in the story of GLP-1 agonists is the overwhelming evidence of their protective effects on the heart and kidneys. Several landmark trials have established these powerful benefits:

The LEADER Trial (Liraglutide): This trial studied patients with type 2 diabetes and high cardiovascular risk. It showed a significant reduction in the risk of major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attack, and non-fatal stroke.
The SUSTAIN-6 and PIONEER 6 Trials (Semaglutide): Both the injectable (SUSTAIN-6) and oral (PIONEER 6) forms of semaglutide were studied in patients with high cardiovascular risk. Both trials demonstrated a robust reduction in MACE, confirming the class effect.
The REWIND Trial (Dulaglutide): What made this trial unique was its focus on a broader population, including many patients who had risk factors for cardiovascular disease but had not yet had an event. It demonstrated that dulaglutide can be used for primary prevention, reducing the risk of a first cardiovascular event.
Tirzepatide (Mounjaro®, Zepbound™): This is a newer, highly potent dual GIP/GLP-1 receptor agonist. While its final CVOTs are still pending as of June 15, 2026, preliminary data suggest powerful cardiovascular benefits are likely.

More recently, the FLOW trial for semaglutide was stopped early because of overwhelmingly positive results showing a significant reduction in the risk of kidney disease progression (nephropathy). These findings are game-changers, solidifying the role of GLP-1 agonists as essential therapies for patients with or at high risk for heart and kidney disease.

Navigating Side Effects and Safety Considerations of GLP-1 Agonists

As with any potent medication, GLP-1 agonists are not without side effects. As clinicians, our job is to help patients navigate these challenges.

Gastrointestinal (GI) Issues: Nausea, vomiting, and diarrhea are common and caused by delayed gastric emptying. My clinical advice is always to “start low and go slow,” beginning with the lowest dose and titrating upwards gradually.
Dehydration and Acute Kidney Injury (AKI): Patients on these medications must drink plenty of water to prevent dehydration due to GI side effects.
Gallbladder Disease: Rapid weight loss, regardless of the method, is associated with an increased risk of gallstone formation.
Pancreatitis: Recent large-scale studies as of early 2025 have been reassuring, finding no statistically significant increase in the risk of pancreatitis and even suggesting a potential long-term risk reduction by improving metabolic health.
Thyroid C-Cell Tumors: These medications carry a black box warning due to an increased risk of thyroid C-cell tumors in rodents. They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Muscle and Bone Loss: This is a feature of significant weight loss in general, not something specific to these drugs. This is where our integrative care becomes critical.

An Integrative Chiropractic Perspective on Metabolic Health

As a Doctor of Chiropractic with advanced training in functional medicine, I view the body as an integrated system. When I see a patient, I don’t just see a person with diabetes and heart disease. I see a complex interplay of systemic inflammation, metabolic dysfunction, and biomechanical stress. This is where our unique approach at Injury Medical Clinic PA provides immense value. The side effects and physiological changes associated with modern diabetes therapies are whole-body issues we can address.
Here’s how integrative chiropractic care fits into this new paradigm:

Addressing Systemic Inflammation: Chronic inflammation is a root cause of both ASCVD and insulin resistance. Chiropractic adjustments have been shown to modulate the nervous system and can have a downstream effect on inflammatory pathways. By reducing spinal misalignments (subluxations), we can help normalize nerve function, which in turn influences the body’s inflammatory response.
Promoting Physical Activity and Combating Muscle Loss: Exercise is a critical component of managing diabetes. However, many patients are limited by musculoskeletal pain. As chiropractors, our primary role is to improve biomechanical function, reduce pain, and restore mobility. Furthermore, with the rapid weight loss induced by GLP-1s, there is a risk of sarcopenia (muscle loss). We implement targeted strength training and rehabilitation protocols to preserve and build lean muscle mass. By treating underlying musculoskeletal issues, we empower patients to engage in the physical activity necessary for their metabolic health.
Functional Medicine and Nutritional Counseling: My training as a Certified Functional Medicine Practitioner (CFMP) allows us to go deeper. We create personalized nutrition plans and recommend targeted supplementation to reduce inflammation, improve insulin sensitivity, and support cardiovascular health. To combat muscle loss, we ensure patients consume adequate protein to support muscle synthesis. This complements the work of medications by addressing the foundational lifestyle factors that drive disease.
Stress Management and Autonomic Balance: The autonomic nervous system plays a huge role in regulating blood pressure, heart rate, and metabolic function. Chronic stress leads to a state of sympathetic (“fight-or-flight”) dominance, which can worsen hypertension and insulin resistance. Chiropractic care, along with techniques like breathwork and meditation, helps promote a parasympathetic (“rest-and-digest”) state, supporting better cardiovascular and metabolic regulation.

In our clinic, a patient would receive a comprehensive plan. Under the medical direction of Dr. Cardenas, they might be started on an SGLT2 inhibitor or a GLP-1 agonist. Simultaneously, my team would work with them on a personalized plan including chiropractic adjustments to improve mobility, an anti-inflammatory diet, and a progressive exercise program they can perform without pain. This integrated approach addresses the disease from multiple angles, leading to far better and more sustainable outcomes. This is the future of chronic disease management—a holistic, patient-centered, and team-based model of care.

References

SEO Tags: SGLT2 inhibitors, GLP-1 receptor agonists, cardiovascular disease, type 2 diabetes, chronic kidney disease, heart failure, integrative chiropractic care, functional medicine, Dr. Alex Jimenez, Dr. Maria Cardenas, El Paso, TX, ASCVD, risk reduction, metabolic health, incretin effect, over-basalization, tirzepatide, semaglutide, Mounjaro, Ozempic, diabetes management, A1c reduction, weight loss and diabetes, nephroprotection, cardioprotection, collaborative care, internal medicine, chiropractic, personal injury care, musculoskeletal health

June 11, 2026

Orthobiologic Insights for Patients and Musculoskeletal Health

Delve into the science of musculoskeletal health and orthobiologic methods to boost recovery and maintain joint well-being.

Abstract

Welcome. I’m Dr. Alex Jimenez, and I am excited to share my perspective on a transformative shift happening in musculoskeletal (MSK) medicine. This educational post, from my viewpoint as a Doctor of Chiropractic and a Family Nurse Practitioner, explores the move from volume-driven to precision-based care in orthobiologics and regenerative medicine. For too long, physicians have been constrained by outdated systems, and patients have been offered limited solutions. This post is for my colleagues in the medical field and for patients seeking a deeper understanding of their health. We will journey through the latest evidence-based findings in orthobiologics, exploring why this field, despite its compelling science, has faced challenges in execution. I will outline a comprehensive framework—the Joint Vitality System—that I have developed to ensure consistent, superior outcomes. This system emphasizes precision diagnosis, biologic matching, and a structured, guided recovery plan.

We will delve into the physiological underpinnings of orthobiologics such as Platelet-Rich Plasma (PRP), contrast them with traditional treatments, and highlight the importance of an integrative model that combines chiropractic care, functional medicine, and medical oversight. The discussion will also cover the critical role of data collection, the importance of understanding the physiological drivers of disease—whether inflammatory, degenerative, or structural—and how our integrative approach at Injury Medical Clinic PA serves as a model for this new paradigm of care. Finally, I will explain how our multidisciplinary team, under the medical direction of Dr. Maria Guadalupe Cardenas, MD, provides a comprehensive framework for restoring function and delivering the transformative, whole-person health outcomes our patients deserve. My goal is to empower you with the knowledge to build or seek a practice that is not only sustainable and independent but also delivers the highest standard of patient-centered, regenerative care.

Our Collaborative and Integrative Approach in El Paso, TX

At Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, our model is built on a multidisciplinary, patient-centered foundation. I am Dr. Alex Jimenez, and I am honored to work alongside our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933) and brings over 40 years of invaluable experience as our Medical Director and Collaborative Physician. This collaboration between a DC/APRN and an MD is a powerful synergy and is common in modern integrative and injury clinics.

This setup allows us to merge the distinct strengths of different medical disciplines to provide truly holistic patient solutions.

Dr. Cardenas (MD, Internal Medicine): Dr. Cardenas provides essential medical oversight, manages complex internal medicine conditions that impact musculoskeletal health, and ensures our protocols meet the highest standards of medical safety and efficacy. Her deep knowledge of systemic disease is critical when evaluating a patient’s candidacy for regenerative procedures, managing lab results, and ensuring our treatments are medically sound.
Dr. Jimenez (DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST): As a Doctor of Chiropractic and a Board-Certified Family Nurse Practitioner with extensive certifications in functional medicine, I focus on the biomechanical, musculoskeletal, and functional aspects of health. My role involves using integrative chiropractic care to address spinal alignment, nervous system function, and structural integrity. As a nurse practitioner and functional medicine expert, I investigate the underlying physiological imbalances—in nutrition, hormones, and inflammation—that contribute to injury and disease.

Together, our team seamlessly integrates chiropractic adjustments, functional medicine diagnostics, medical management, rehabilitation, personal injury care, and orthobiologic therapies into a single, cohesive care plan. This allows us to address the patient as a whole person, not just an injured joint. For instance, before a regenerative procedure, we might use chiropractic care to ensure proper joint mechanics, functional medicine to optimize nutrient levels and reduce systemic inflammation, and medical oversight from Dr. Cardenas to manage a patient’s previously undiagnosed pre-diabetes—all of which are crucial for a successful outcome.

Rethinking the Business of Medicine: From Fear to Freedom

Many of us in the medical field come from the “School of Hard Knocks” when it comes to business. We’re trained to believe that if we don’t know every single detail about a subject, we shouldn’t even start. This mindset is rooted in our primary directive: “first, do no harm.” We fear that an error in judgment could have devastating consequences for a patient. However, I want to offer a different perspective: business is not as hard as medicine. The risks are fundamentally different.

What’s the worst that can happen in a small business venture? You don’t charge as much as you could have. You lose a little money one month, which you can make up the next. You buy ten units of a product instead of twenty to save on upfront costs, even if the per-unit price is slightly higher.
Were these devastating choices? Did anyone get harmed? Perhaps your bank account was temporarily a few dollars lighter, but that’s just the price of doing business and learning.

Most entrepreneurs “build the airplane while they’re flying it.” They just get started and figure things out along the way. As clinicians, we are incredibly smart and adept at learning. My own journey into private practice started with a copy of Medical Practices for Dummies. It got me surprisingly far! I missed a step about getting a business license right away, but it was easily corrected. No harm, no foul. The point is, it can all be figured out.

The Orthomolecular Micro-Practice: Precision Over Volume

The model I champion is what I call the orthomolecular micro-practice. This is not a volume-driven enterprise; it is a precision practice. In the traditional insurance-based world, the only way to increase revenue is to see more patients because the price per visit is fixed and often low. This leads to burnout, rushed appointments, and mountains of paperwork.

Consider this brutal statistic we’ve observed: the ratio is approximately 15:1. To earn the same revenue from a single orthobiologic cash-based procedure, I would need to see 15 insurance-based patients. If I see 30 patients in a day under the insurance model, I make the same amount as seeing just two or three orthobiologic patients. Think of the administrative burden: would you rather write 30 clinical notes or just two? The answer is obvious.

This is where technology like an AI scribe becomes a game-changer. I personally use a system (DeepScribe) that requires no clicks from me. I record my patient interactions, and by the time I leave the room, the note is fully and directly imported into my EMR. It saves an incredible amount of non-compensated time and allows me to be fully present with my patients.

The Precision Practice is built on a few core principles:

Precision over Volume: Focusing on a smaller number of patients allows for deeper, more comprehensive care.
Systems-Driven Approach: Every patient touchpoint, from the initial phone call to the follow-up, is standardized. This ensures a predictable, high-quality experience and makes the practice scalable without sacrificing consistency.
The Right Patients: We focus on attracting patients who are actively seeking the transformative solutions we offer. We don’t convince or use high-pressure sales tactics. We educate, present the expected outcomes, and empower them to make an informed decision.

Seeing just five to ten of these ideal patients a month can build a thriving, sustainable practice. Ten patients a month at an average of 50,000 in cash revenue. That’s a legitimate business that can cover payroll, rent, and more—all while seeing only ten patients a month.

Patient-Centered Outcomes Over Procedures: Why Value Is About Transformation

As a clinician, I have learned that patients do not come to us for injections—they come for transformation. They want their lives back: to lift grandchildren, to play pickleball, to work without pain, to sleep through the night, and to feel strong and capable again. This distinction guides everything we do.

Patients are not purchasing a syringe; they are investing in a meaningful outcome.
When care results in real, measurable functional restoration, it justifies expert-level compensation because it delivers lasting value.
The ethical compass remains true when we provide evidence-based methods, conduct meticulous data collection, and set transparent expectations for recovery.

In our clinic’s integrative system, we package what matters: a pathway that blends orthopedic and nervous system restoration, lifestyle changes, and structured rehabilitation. The end goal is simple: unlock the patient’s innate capacity for repair, and then guide it with science-backed steps.

Unlocking Pain Relief: How We Assess Motion to Alleviate Pain- Video

The Challenge of Execution in Orthobiologics

On May 2, 2026, I reflected on the state of orthobiologics, and it became clearer than ever that the science is not the issue. The research supporting the use of biologics such as Platelet-Rich Plasma (PRP) and Bone Marrow Concentrate (BMC) is compelling and continues to grow daily. We have evidence showing we can modify the inflammatory environment of a joint and even stimulate the replication of tenocytes (tendon cells).

So why isn’t this the first-line treatment for every appropriate MSK condition? The answer lies in execution. We’ve seen significant problems that have eroded patient trust and caused physician hesitation:

Inconsistent Outcomes: Clinic A’s PRP protocol differs markedly from Clinic B’s. This lack of standardization leads to unpredictable results.
Poor Patient Selection: A common pitfall is offering a single therapy for every condition. PRP is fantastic for many tendon-based issues, but it won’t cure severe, bone-on-bone hip arthritis with significant bone marrow edema. Using the wrong tool for the job is a recipe for failure.
Overpromising in Marketing: We’ve all seen the “stem cell” clinics that make miraculous claims without proper diagnostics or patient evaluation. This “Wild West” atmosphere, particularly prevalent in places like Florida, erodes public trust. The key is to under-promise and over-deliver.
Lack of Standardization and Measurement: As a field, we must be rigorous. Leading researchers have shown that a platelet dose above 5.5 billion is associated with more beneficial outcomes (Everhart et al., 2019). Are we measuring the platelet concentration in every PRP sample we prepare? We should be. If you can’t measure, you should at least know your system’s validated output. For instance, in our clinical observations, using a specific 60 cc draw with the Apex kit consistently yields approximately 10.8 billion platelets. This knowledge allows us to ensure we are delivering a therapeutic dose every single time.

These execution failures drive patients away from a field with immense potential and cause good physicians to second-guess their approaches. To ensure consistency and scalability, I developed the Joint Vitality System. This is not just a procedure; it is a comprehensive framework that guides our entire process, from initial consultation to full recovery.

The Joint Vitality System Part 1: Precision Diagnosis Beyond the Obvious

A successful outcome starts with an accurate and precise diagnosis. We cannot afford to guess. This requires a multifaceted approach:

Thorough History and Physical Exam: We must listen to our patients and touch our patients. You can have two patients with identical MRI reports but completely different sources of pain. One might have true intra-articular knee pain from synovitis, while the other’s “knee pain” is actually referred pain from an L4 radiculopathy or hip arthritis.
Diagnostic Musculoskeletal Ultrasound: This is not optional. It is a vital point-of-care tool that allows us to visualize tissues in real time, assess for inflammation, and pinpoint the exact source of pain. I can move the joint and ask, “Does it hurt right here?” while visualizing the underlying anatomy.
Reviewing Your Own Imaging: While radiologists’ reports are important, MSK-trained clinicians often see subtleties that general radiologists may miss. They might not comment on a high-intensity zone in a disc, a low-grade partial tendon tear, or a meniscocapsular junction sprain—all of which are significant pain generators that we can treat with orthobiologics.
Diagnostic Injections: I am a firm believer in the “show me” principle. If I am not 100% certain of the pain generator, I use diagnostic injections (e.g., with a local anesthetic) to confirm the source. This is a powerful tool. If numbing a specific structure provides significant temporary relief, we have confirmed our target. It’s a “try it before you buy it” approach for orthobiologics that gives both the patient and me confidence in the treatment plan.

We must differentiate between an inflammatory driver, a degenerative driver, and a structural driver. For example, a hot, swollen knee might be driven by inflammation (synovitis). In contrast, a chronically achy, mechanically unstable knee might be driven by degeneration (arthritis) or a structural problem (e.g., a meniscus tear). Each requires a different approach.

The Joint Vitality System Part 2: Biologic Matching for the Right Job

Once we have a precision diagnosis, we must match it with the appropriate biologic therapy. It is not a one-size-fits-all solution. The key question is: What does this specific tissue need to achieve our therapeutic goal?

Inflammation Control: If the primary problem is inflammation, our goal is immunomodulation. We need to flip pro-inflammatory M1 macrophages to an anti-inflammatory M2 phenotype. When this occurs in the knee synovium, something remarkable happens: the synovium begins to produce its own endogenous hyaluronic acid (Morigi et al., 2020). We can stimulate the body to heal itself.
Cellular and Growth Factor Support: For degenerative conditions like tendinopathy or mild-to-moderate arthritis, PRP is an excellent choice. It delivers a high concentration of growth factors that signal tissue repair and reduce inflammation. We tailor the leukocyte profile, using leukocyte-rich PRP for ligament/tendon issues and leukocyte-poor PRP for intra-articular arthritis to better modulate local inflammation (Dohan Ehrenfest et al., 2009).
Structural Scaffolding and Cellular Regeneration: For more significant issues, like a partial tendon tear with a visible gap or more advanced arthritis, we need more. Adipose tissue provides a structural scaffold (the extracellular matrix) and a rich source of mesenchymal stem cells (MSCs) and other regenerative cells. If there is a gap in a tendon that needs bridging, adipose is a superb option.
Bone and Cartilage Healing: For severe arthritis with associated bone marrow edema (a sign of stress and inflammation within the bone itself), Bone Marrow Concentrate (BMC) is often the superior choice. BMC contains MSCs and other progenitor cells that are crucial for bone and cartilage health. It is also a flowable product that can be injected intraosseously (directly into the bone) to treat bone marrow lesions, a capability not available with thicker adipose grafts.

We must also consider the delivery method. Putting an adipose graft (which requires an 18-gauge needle) into an intervertebral disc is not a sound application. The biologic must be appropriate for the tissue, the pathology, and the delivery method.

The Joint Vitality System Part 3: Structured Care and Guided Recovery

The procedure is just one part of the journey. A structured care plan is essential for guiding the patient and managing their expectations from start to finish. This includes a comprehensive rehabilitation program that turns improved biology into durable function. We use staged, criterion-based protocols:

Early phase (days 1–14): Protect the site, restore pain-free range of motion, gentle isometrics, and controlled closed-chain loading to stimulate mechanotransduction without overstrain.
Mid phase (weeks 3–8): Progressive resistance, eccentric training for tendons, neuromuscular control (balance, perturbation training), and pattern correction (hip hinge, scapular setting).
Late phase (weeks 9–16): Power development, return-to-sport drills, and task-specific conditioning (e.g., pickleball pivot work, lifting technique for grandparents).

If we perform a procedure on a tendon, the patient must follow a progressive tendon-loading program. This is non-negotiable. The mechanical signals from proper physical therapy are essential for guiding the new tissue as it remodels and strengthens. This is known as mechanotransduction, where cells sense load and trigger gene expression for collagen synthesis and alignment (Wang et al., 2012). Eccentric loading, in particular, promotes tendon remodeling.

Why We Start 30 Days Before the Procedure: Health Optimization and Risk Reduction

True recovery begins before the day of the procedure. Our pre-procedure window—often 30 days—allows us to “stack the deck” for repair. This whole-person approach is critical because healing is metabolically expensive.

Key optimization targets:

Hematologic readiness: We review complete blood count and iron studies. Adequate oxygen-carrying capacity is vital for cellular respiration and ATP production during healing (Stoltzfus et al., 2019).
Endocrine balance: We test thyroid function and sex hormones, such as estrogen and testosterone. We now know there are estrogen receptors in the knee, and estrogen has a protective effect on cartilage. Its decline during menopause is linked to an earlier onset of arthritis in women—sometimes 20 years sooner than in men (Sniekers et al., 2008). Optimizing hormones when clinically indicated supports collagen synthesis, bone density, and muscle integrity (Khosla & Monroe, 2018).
Nutritional status: We test for Vitamin D and other key nutrients. Ensuring adequate intake of vitamin D, omega-3 fatty acids, magnesium, and protein supports immune modulation and connective tissue repair (Calder, 2017; DiNicolantonio et al., 2018).
Glycemic control: An elevated Hemoglobin A1C indicates poor blood sugar control, which severely impairs healing. Lowering HbA1c improves microvascular function, reduces glycation end products, and enhances wound-healing quality (Singh et al., 2020).
Sleep and circadian alignment: Consistent sleep boosts growth hormone pulses and tissue repair, while circadian regularity improves insulin sensitivity and inflammatory tone (Luyster et al., 2012).

The Role of Integrative Chiropractic Neuromechanics in Recovery

Integrative chiropractic care is foundational for translating biological repair into functional performance. It is a key component of our guided recovery, helping prevent the recurrence of underlying mechanical stresses that may have caused the problem in the first place.

The physiology behind this approach is powerful:

Joint alignment and segmental mobility restore optimal arthrokinematics, reducing shear stress on healing tissues.
Proprioceptive enhancement recalibrates spinal and peripheral reflex loops, improving muscle firing patterns and reducing compensatory overuse. Pain alters motor control via central sensitization. Chiropractic adjustments help normalize afferent input to the nervous system, reducing hypervigilant reflexes.
Fascial release and myofascial remodeling improve glide planes, reducing nociceptive input and allowing normalized movement arcs.
Improved joint centration and balanced muscle co-contraction decrease joint microinstability, protecting healing cartilage and tendons from irregular load vectors.

My clinical observations confirm that pairing PRP with chiropractic-guided kinetic chain correction leads to faster time-to-function milestones and fewer relapses, especially in shoulder, knee, and lumbar dysfunctions (Jimenez, n.d.-a; Jimenez, n.d.-b). It ensures the body is optimally aligned to heal.

The Power of Relationships and Your Existing Patient Base

So, how do you find these patients? The growth of a successful orthobiologics practice comes from relationships. The two most powerful and durable sources of growth are:

Clinician Referrals: Building a referral-based practice is the most sustainable model. We position ourselves as problem-solvers for our colleagues. An orthopedic surgeon sees many patients with non-surgical conditions, such as greater trochanteric bursitis (lateral hip pain). These cases rarely proceed to surgery and can be frustrating for a surgeon to manage. For us, it’s a perfect opportunity to apply orthobiologics.
Your Existing Patient List: Your most valuable asset is the group of patients who already know, like, and trust you. The cost to reach a patient who is already in your system is zero. They haven’t heard from you about these new treatments because you haven’t offered them yet!

Let me share an example. I used to perform a lot of hyaluronic acid (HA), or “gel,” injections for knee arthritis. When I decided to stop, I contacted all my HA patients and explained that based on the latest evidence, PRP offered a superior outcome. I gave them the choice: transition to PRP with me or receive a referral for HA. The result? Thirty percent of my HA patients transitioned to orthobiologic care. The research supports this move. Studies, such as the one by Meheux et al. (2016), consistently show that PRP outperforms HA at every time point in treating knee osteoarthritis. When we educate patients, many will opt for the better outcome.

Data Collection: The DNA of Continuous Improvement

We collect data because better measurement produces better outcomes. If you are not collecting data on your patients, you are flying blind. I strongly advocate for using a registry like DataBiologics, founded by physicians for physicians. It provides an IRB-approved platform to track outcomes, allowing us to publish our data and, most importantly, tell our patients with confidence what they can expect from our specific treatments in our clinic.

What we track:

Pain scores (NRS/VAS), function scales (e.g., DASH, LEFS, Oswestry Disability Index), and patient-reported improvements.
Baseline and follow-up metrics for strength, mobility, and balance.
Adherence markers for nutrition, sleep, and activity.

A nominal $25 data fee added to the care package can cover system costs and foster engagement. This is how we move from anecdote to evidence. This is how we build trust.

Conclusion: A Modern, Evidence-Based Pathway to Recovery

The train of regenerative medicine is leaving the station. Our integrative framework, guided by medical oversight from Dr. Maria Guadalupe Cardenas, MD, and chiropractic leadership from me, delivers a measured, ethical, and effective route to patient transformation. We start early, combine biologic precision with biomechanical intelligence, optimize metabolism, and move patients through staged rehabilitation. We measure relentlessly, learn constantly, and stay aligned as a team. By embracing a systematic, evidence-based, whole-person approach, we can provide our patients with the exceptional care they deserve while building practices that are professionally and financially rewarding. This is how we practice medicine on our own terms, driven by science and a genuine desire to help our patients heal.

References

Calder, P. C. (2017). Omega-3 fatty acids and inflammatory processes: From molecules to man. Biochemical Society Transactions. https://doi.org/10.1042/BST20160474
Chahla, J., et al. (2017). Bone marrow aspirate concentrate for the treatment of chondral defects of the knee: A systematic review of outcomes. Orthopedic Journal of Sports Medicine. https://doi.org/10.1177/2325967117702367
Dohan Ehrenfest, D. M., et al. (2009). Classification of platelet concentrates (PRP, PRF) and injectable platelet-rich fibrin (i-PRF): Rationale and perspectives. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2009.06.004
DiNicolantonio, J. J., et al. (2018). Magnesium for the prevention and treatment of cardiovascular disease. Open Heart. https://doi.org/10.1136/openhrt-2018-000775
Everhart, J. S., Cavendish, P. A., & Flanigan, D. C. (2019). Platelet-Rich Plasma Preparation and Composition. In Platelet-Rich Plasma in Orthopedics and Sports Medicine (pp. 43-60). Springer, Cham. https://link.springer.com/chapter/10.1007/978-3-030-01957-2_4
Filardo, G., et al. (2020). PRP intra-articular injections for knee osteoarthritis: A systematic review of clinical outcomes. Arthroscopy. https://doi.org/10.1016/j.arthro.2020.01.044
Griffin, T. M., & Scanzello, C. R. (2019). Innate inflammation and adiposity in osteoarthritis. Current Opinion in Rheumatology. https://doi.org/10.1097/BOR.0000000000000602
Jimenez, A. (n.d.-a). Clinical insights and integrative chiropractic care. ChiroMed.
Jimenez, A. (n.d.-b). Professional profile and clinical posts. LinkedIn.
Khosla, S., & Monroe, D. G. (2018). Regulation of bone metabolism by sex steroids. Cold Spring Harbor Perspectives in Medicine. https://doi.org/10.1101/cshperspect.a031211
Laudy, A. B., et al. (2015). Efficacy of PRP injections in the treatment of tendinopathy: A systematic review and meta-analysis. British Journal of Sports Medicine. https://doi.org/10.1136/bjsports-2014-094700
Luyster, F. S., et al. (2012). Sleep health and positive aging: A systematic review. Journal of Aging and Health. https://doi.org/10.1177/0898264311428167
Meheux, G. J., McCulloch, P. C., Lintner, D. M., Varner, K. E., & Harris, J. D. (2016). Efficacy of Intra-articular Platelet-Rich Plasma Injections in Knee Osteoarthritis: A Systematic Review. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 32(3), 495–505.
Messier, S. P., et al. (2013). Weight loss reduces knee-joint loads in overweight and obese adults with knee osteoarthritis. Arthritis & Rheumatism. https://doi.org/10.1002/art.34684
Morigi, M., Introna, M., Remuzzi, G., & Rota, C. (2020). The multifaceted roles of mesenchymal stromal cells in homeostasis, autoimmunity, and cancer. EMBO Journal, 39(22), e106536. https://www.embopress.org/doi/full/10.15252/embj.2020106536
Nabavi, S. M., Šamec, D., Tomczyk, M., Milella, L., Ribaudo, L., Said, R. B., … & Devi, K. P. (2017). Flavonoid biosynthetic pathways in plants: a good source of health-promoting molecules. International Journal of Molecular Sciences, 18(9), 2011.
Singh, V. P., et al. (2020). Advanced glycation end products and diabetic complications. The Korean Journal of Physiology & Pharmacology. https://doi.org/10.4196/kjpp.2020.24.1.1
Sniekers, Y. H., Weinans, H., Bierma-Zeinstra, S. M. A., van Leeuwen, J. P. T. M., & van Osch, G. J. V. M. (2008). Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment – a systematic review. Osteoarthritis and Cartilage, 16(5), 533–541. https://www.osteoarthritisandcartilage.com/article/S1063-4584(07)00350-0/fulltext
Stoltzfus, R. J. (2019). Research and policy implications of the iron-endowed woman. The Journal of Nutrition, 134(4), 867- 871. https://doi.org/10.1093/jn/134.4.867
Wang, J. H.-C., et al. (2012). Mechanobiology of tendon. Journal of Biomechanics. https://doi.org/10.1016/j.jbiomech.2011.11.002

SEO Tags: orthobiologics, regenerative medicine, chiropractic care, integrative medicine, integrative chiropractic, Dr. Alex Jimenez, Dr. Maria Cardenas, El Paso TX, Platelet-Rich Plasma, PRP, PRP knee osteoarthritis, Bone Marrow Concentrate, BMC, musculoskeletal health, functional medicine, precision diagnosis, Joint Vitality System, stem cell therapy, sustainable medical practice, patient-centered care, evidence-based medicine, ultrasound-guided injections, tendon loading, hormone therapy, menopause and joint pain, guided rehabilitation, El Paso chiropractor, internal medicine medical director, weight loss arthritis, data collection outcomes, mechanotransduction, collagen synthesis, bone marrow aspirate concentrate, multidisciplinary injury clinic, Mission Plaza Injury Medical Clinic, Injury Medical Clinic, Precision Medicine, Knee Pain, Arthritis Treatment, Business of Medicine, Systems-Driven Practice, Whole Person Health

June 9, 2026

Photobiomodulation for Pain Relief and Recovery

Abstract

This educational article explores the profound cellular mechanisms behind Photobiomodulation Therapy (PBMT), often known as laser therapy, and its transformative potential in modern medicine. From a first-person perspective, I will guide you through the scientific journey of how light energy interacts with our cells to promote healing, reduce inflammation, and restore function. We will delve into the latest findings from leading researchers, explaining how PBMT activates mitochondria, modulates cytokine responses, and stimulates tissue regeneration across nerves and muscles. This post will also illuminate the synergistic relationship between PBMT and orthobiologics such as Platelet-Rich Plasma (PRP), demonstrating how combining these therapies can enhance clinical outcomes. Finally, I will explain how we integrate these advanced modalities at our clinic, where a multidisciplinary team approach, featuring integrative chiropractic care alongside medical oversight, provides a comprehensive and evidence-based path to recovery for our patients.

A Personal Journey into the Power of Light

After nearly a decade in this field, I feel like I’ve finally found my people. For years, mentioning the word “laser” in medical circles felt like an uphill battle. I faced skepticism and resistance—metaphorical rotten tomatoes and broken beer bottles for the first five years. Many of you in the regenerative medicine space can likely relate to that struggle. Pushing the boundaries of biologic-based therapies has been a similar journey. That’s why I am so thrilled to have the opportunity to share my experience and the powerful science that has not only vindicated this work but is now revolutionizing how we approach healing.

It all begins with a fundamental biological principle we often overlook: photosynthesis. The sun shines, plants grow, and they sustain life on our planet. We, as a species, have evolved over hundreds of thousands of years under that very sun. Our cells, down to their deepest genetic components, have developed a sensitivity to light.

Think about it this way: from our first days in medical school, we are taught that sunlight is essential for vitamin D synthesis. We accept this without question. Yet a significant gap exists in modern medical education regarding the broader therapeutic applications of light—a field known as Photobiomodulation Therapy (PBMT). This post is my effort to bridge that gap and explain how we can harness light to unlock the body’s innate ability to heal itself.

Our Integrative Approach at Injury Medical Clinic

At our practice, Injury Medical Clinic PA, we believe in a team-based, patient-centered model. My role as a Doctor of Chiropractic (DC) with advanced training as a Nurse Practitioner (APRN) and in Functional Medicine (CFMP, IFMCP) is to focus on the biomechanical, neurological, and metabolic aspects of health. I am privileged to work alongside Dr. Maria Guadalupe Cardenas, MD, a Board-Certified Internist with over 40 years of invaluable experience. Dr. Cardenas serves as our Medical Director and Collaborative Physician, providing essential medical oversight and ensuring our patients receive comprehensive, integrated care.

This multidisciplinary setup allows us to blend the best of different worlds:

Chiropractic Care: We address musculoskeletal alignment, nerve function, and biomechanics to restore the body’s structural integrity.
Medical Oversight: Dr. Cardenas provides the medical diagnosis, management, and direction necessary for complex cases, especially in personal injury and chronic disease.
Functional Medicine: We investigate the root causes of dysfunction, considering genetics, lifestyle, and environmental factors to develop personalized treatment plans.
Advanced Therapies: We incorporate cutting-edge modalities like Photobiomodulation (PBMT) and orthobiologics to accelerate healing at the cellular level.

This collaborative environment ensures that when we recommend a therapy like PBMT, it is part of a holistic strategy designed to treat the whole person, not just the symptom.

What is Photobiomodulation? Understanding the Language of Our Cells

Let’s break down the term:

Photo: Light
Bio: Life
Modulation: To affect or change

Photobiomodulation is the process of using light to create a biological change. We know that light is energy, and its fundamental units are photons. Think of photons as the currency of light energy. When these photons penetrate our tissues, they transfer their energy to our cells, initiating a cascade of biological responses.

For the first twenty years of my practice, I was a mechanic, using tools to “fix” conditions. For the last ten, I have become more of a biologist, focused on creating the right environment for the body’s own cells to orchestrate a healing response. Cellular recovery is the goal, and this is where PBMT truly shines.

The Cellular Mechanisms: From Mitochondria to Tissue Repair

Everyone is talking about mitochondrial health and ATP production, but the effects of PBMT go much deeper. Let’s explore the documented cellular reactions that translate into the clinical outcomes we see every day—less pain in the shoulder, knee, or elbow.

1. Mitochondrial Activation and Energy Production

The primary target of PBMT within our cells is an enzyme in the mitochondria called cytochrome C oxidase. This enzyme is a photoacceptor, meaning it is specifically designed to absorb light. When photons of the correct wavelength strike this enzyme, it becomes more active. This supercharges the Krebs cycle, leading to several critical downstream effects:

Increased ATP Production: The cell’s energy currency is produced in greater abundance, providing the fuel needed for repair and function.
Modulation of Reactive Oxygen Species (ROS): While high levels of ROS cause oxidative stress, a transient, controlled increase acts as a crucial signaling molecule.
Release of Nitric Oxide: Light can displace nitric oxide bound to cytochrome c oxidase, allowing oxygen to bind more efficiently and increasing cellular respiration. The released nitric oxide then acts as a vasodilator, improving local blood flow.

This initial spark in the mitochondria triggers a cascade that sends messages all the way to the cell’s nucleus, initiating gene transcription. This is how the cell starts producing the proteins and signaling molecules—cytokines—that direct the healing process.

2. Immune Modulation: Shifting from Inflammation to Repair

When you sustain an injury, your body floods the area with pro-inflammatory cytokines to kickstart the healing process. However, in chronic conditions, this inflammatory state can become “stalled,” preventing true recovery. PBMT helps modulate this immune response.

We can scientifically document that PBMT, using the right wavelength and dose, can:

Increase anti-inflammatory cytokines, such as interleukin-10 (IL-10).
Reduce pro-inflammatory cytokines, such as interleukin-6 (IL-6).

Essentially, PBMT helps guide the body out of the persistent inflammatory phase and into the reparative, healing phase.

3. Enhancing Blood Flow and Nerve Regeneration

The benefits continue to cascade through the body’s systems:

Angiogenesis: PBMT has been shown to stimulate angiogenesis by promoting the production of cytokines, including galectin-1. Improved microcirculation is fundamental for delivering oxygen and nutrients to damaged tissue and removing waste products.
Neurogenesis: We can even see improvements at the neuronal level. Studies have demonstrated that PBMT can upregulate proteins like hnRNP K, which are involved in axonal growth and neuronal repair. This is why it’s so effective for nerve-related pain and injury recovery.

4. Accelerating Muscle and Connective Tissue Recovery

Muscle Recovery: Using electron microscopy, researchers have confirmed that PBMT improves muscle cell development and increases myoglobin production, thereby enhancing oxygenation and speeding recovery after exertion or injury.
Fibroblast Activation: Fibroblasts are the body’s master builders, responsible for producing collagen and forming the structural framework for tissue repair. PBMT provides the energy these cells need to activate and get to work, which is why it pairs so well with orthobiologics that send the initial “go” signal.

By targeting these fundamental cellular processes, PBMT doesn’t just treat conditions like tendonitis or arthritis; it also treats the dysfunctional cells within the pathological tissue. It changes the cellular environment to one that fosters healing. That’s why it has such a broad range of applications for anything that ends in “-itis.”

The Science of Light: Wavelength, Penetration, and the Therapeutic Window

Not all light is created equal. The electromagnetic spectrum ranges from deadly gamma rays with very short wavelengths to harmless radio waves with very long wavelengths. There is a specific “therapeutic window” for PBMT, typically between 600 nanometers (red light) and 1200 nanometers (near-infrared light).

Why is this range so important? It’s all about penetration. To be effective, photons must reach the target tissue. Three primary obstacles stand in their way: skin, blood (hemoglobin), and water. The wavelengths within the therapeutic window are most adept at bypassing these absorbers and penetrating deep into the body, where musculoskeletal injuries reside.

Red light (around 600-700 nm) is excellent for superficial tissues. It penetrates only a few millimeters, making it great for skin conditions, but it won’t reach deep muscles or joints.
Near-infrared light (around 800-1100 nm) penetrates much deeper, making it the workhorse for orthopedic and musculoskeletal conditions.

At our clinic, we use advanced systems like MLS (Multiwave Locked System) Laser Technology. I am a huge fan of this technology because it synchronizes two different wavelengths—one continuous and one pulsed. The pulsed wavelength, which fires thousands of times per second, allows the tissue to absorb light energy without building up excessive heat. This makes the treatment incredibly safe and effective, allowing for unattended application without the risk of thermal damage.

The Clinical Applications: From Acute Injury to Chronic Pain

In my practice, which includes serving as a team physician for a Division I school, we use PBMT across a spectrum of conditions:

Acute Injuries: For our athletes, PBMT is a go-to for sprains, strains, and contusions. It significantly reduces recovery time and gets them back on the field faster.
Post-Operative Recovery: Surgery is, in essence, a controlled acute injury. We use PBMT postoperatively to reduce swelling, bruising, and pain, resulting in cleaner incisions and significantly improved patient-reported outcomes.
Chronic Inflammatory Conditions: For issues such as a thickened Achilles tendon or degenerative joint disease, where the inflammatory process is stalled, PBMT can reignite the healing cascade.

The evidence is overwhelming. With over 7,000 published studies, PBMT is gaining recognition from major health organizations. The Centers for Disease Control (CDC) mentions “laser photobiomodulation” dozens of times in its revised opioid guidelines as a non-pharmacological option for acute, subacute, and chronic pain. The science is no longer theoretical; it’s a clinical reality.

The Ultimate Synergy: Combining PBMT with Orthobiologics

This is where the magic truly happens. Orthobiologics like Platelet-Rich Plasma (PRP) are rich in growth factors and anti-inflammatory proteins. They are a powerful message sent to the site of injury, instructing the local cells to begin the repair process.

Now, imagine giving those cells the fuel they need to carry out those instructions. That is what PBMT does.

Orthobiologics provide the blueprint (the message).
PBMT provides the energy (the fuel).

By combining these two therapies, we are creating the optimal environment for cellular activity, healing, and regeneration. People are starting to talk about this synergy. A landmark study in the veterinary world—where patients don’t have secondary gain or placebo effects—provided powerful proof (Ferreira et al., 2021). In this canine study on knee osteoarthritis, dogs were treated with PBMT alone, then PRP alone, and finally a combination of both. The results were clear: the combination therapy produced significantly better outcomes.

The Future is Biology: A Glimpse into Our Research

We are committed to contributing to this growing body of evidence. I’m incredibly proud to share a “proud dad moment.” My son, Zachary, recently completed a study at the Mass General Brigham Enable BioSkills Lab. We took human tenocytes (tendon cells) and applied our laser over them.

The results were astounding: we demonstrated a 20% dose-dependent increase in tenocyte proliferation from PBMT alone.

We are literally proving that we can make tendon cells multiply with light. Our next steps involve qPCR to analyze gene expression and ELISA to measure protein levels. This research helps us move from anecdotal success to hard, reproducible science. The future of orthopedics isn’t just metal and screws; it’s biology. It’s about working with the body, not just on it.

From modulating inflammation to fueling cellular engines, Photobiomodulation Therapy has proven itself to be a cornerstone of modern, integrative care. I’ve witnessed its power firsthand, and I am honored to share this knowledge with you. It has been a pleasure to take you on this journey into the science of light and healing.

References

Ferreira, M. P., Tucholski, G. Z., Dória, R. G. S., de Oliveira, B. C., Pimpão, C. T., & De Nardi, A. B. (2021). Intra-articular injections of platelet-rich plasma and photobiomodulation therapy (904 nm) for the treatment of canine osteoarthritis: A double-blinded, randomized clinical trial. Research in Veterinary Science, 139, 270–279. https://doi.org/10.1016/j.rvsc.2021.07.027
Jimenez, A. (n.d.). Clinical Observations. Retrieved from https://chiromed.com/ and https://www.linkedin.com/in/dralexjimenez/

June 2, 2026

Restoring Musculoskeletal Function: Integrative Care

Abstract

In this educational post, I will take you on a journey into the future of musculoskeletal treatment, moving beyond isolated symptom management to a comprehensive, whole-body paradigm. We will explore interventional orthopedics, which uses precise, image-guided techniques to target the root causes of pain. Building on this, I will introduce a concept I call functional orthopedics and the functional unit approach—a philosophy that integrates the principles of osteopathic medicine, physical medicine, and regenerative science. This approach emphasizes understanding the intricate connections between structure and function, the body’s innate healing capacities, and the importance of treating the entire biomechanical chain rather than just the site of pain. We will delve into the latest evidence-based research by leading experts, examining the critical roles of subchondral bone, intraosseous injections, and comprehensive treatment strategies for conditions such as osteoarthritis. By combining these advanced concepts with the foundational principles of integrative chiropractic care, we can create truly personalized and effective treatment plans that offer lasting relief and restore optimal function.

Understanding the “How” and “Why” of Modern Musculoskeletal Treatment

Thank you for joining me on this exploration of a truly transformative approach to musculoskeletal health. What we are about to discuss is an integral part of a new way of thinking in medicine, and I believe it can fundamentally change how we help our patients heal. Today, we’re not just talking about another treatment method; we’re diving into the “how, why, and what” of a more profound, evidence-based strategy.

The How: The “how” is our interventional orthopedic approach.
The Why: The “why” is rooted in functional orthopedics and the functional unit approach.
The What: The “what” is the application of these principles to deliver comprehensive, patient-centered care.

Let’s unpack what this all means for you and your health journey.

What is Interventional Orthopedics?

Interventional orthopedics represents a significant evolution from traditional pain management. It’s a specialized field that focuses on using the body’s own healing potential to repair and regenerate damaged tissue. The core principle is precision. Instead of just managing symptoms, we aim to treat the underlying source of the problem.

This isn’t about simply injecting a painful joint and hoping for the best. It’s about a meticulous process in which we use advanced imaging, such as ultrasound and fluoroscopy, to visualize and precisely target specific structures. Whether it’s a torn ligament, a damaged tendon, or degenerative changes within a joint, we can deliver orthobiologic treatments—such as Platelet-Rich Plasma (PRP) or Bone Marrow Aspirate Concentrate (BMAC)—directly to the site of injury with pinpoint accuracy.

The goal is to move beyond treating “the thing that is causing the pain” and instead look at the entire picture. But how do we decide what to target? That’s where the “why” comes into play.

Introducing Functional Orthopedics: A Philosophy of Whole-Body Healing

This brings me to a concept that is the cornerstone of my clinical philosophy: functional orthopedics. While you might not find this term in a standard medical textbook (I coined it to describe my integrated approach), its principles are not new. They are deeply rooted in my training as an osteopathic physician, a chiropractor, and a functional medicine practitioner.

Functional orthopedics is guided by several core tenets:

The body is a unit: No part of the body exists in isolation. A problem in your foot can affect your knee, which can in turn impact your hip and spine. Everything is connected.
Structure and function are interrelated: The way your body is built (structure) directly influences how it moves and operates (function), and vice versa. An imbalance in one will inevitably affect the other.
The body has self-healing mechanisms: it possesses an incredible, innate ability to heal and regenerate. The role of a physician is to facilitate and optimize these natural processes.
Rational treatment is based on these principles: The most effective and lasting treatments are those that honor and work with the body’s integrated design.

This philosophy is a synthesis of my background in Physical Medicine & Rehabilitation (PM&R), which focuses heavily on structure and function, and regenerative medicine, which harnesses the body’s self-healing capabilities. By applying the functional medicine model, we look for the root causes of a condition, considering all the factors—biomechanical, nutritional, and environmental—that contribute to a patient’s health state.

The Functional Unit Approach: Treating the System, Not Just the Symptom

The practical application of functional orthopedics is what I call the functional unit approach. This concept was first described in an old surgical textbook by Dudley and White, who defined the “functional spinal unit” (Dudley & White, n.d.). They recognized that treating a single vertebra or disc was often insufficient because the spine functions as an interconnected system.

We now see this comprehensive approach being validated by modern research in orthobiologics. Several recent studies have demonstrated the superior, long-term benefits of treating the entire functional unit of the spine. For example, researchers have published compelling papers on the use of PRP and BMAC not only in the epidural space but also in the facet joints, ligaments, and paraspinal muscles to treat lumbar and cervical spine issues (Centeno et al., 2017). By addressing all the components that contribute to spinal stability and function, patients experience more profound and lasting results.

This isn’t limited to the spine. A landmark study on knee osteoarthritis compared outcomes between patients who received only an intra-articular (in-joint) injection and those who received both intra-articular and extra-articular (outside the joint) treatments. The results were clear: while both groups improved, the group treated more comprehensively experienced significantly better and more durable outcomes (Centeno et al., 2020).

Think about it from a clinical perspective. How many times have I seen a patient with mild knee osteoarthritis who also has pes anserine bursitis, hamstring tendinopathy, or tenderness along the ligaments? Pain isn’t just coming from the joint space. It’s coming from the entire functional unit that supports and moves that joint. The paradigm shift is from a narrow, intra-articular focus to a comprehensive view encompassing all intra-articular and extra-articular structures.

Beyond the Joint: The Critical Role of Subchondral Bone

But does it stop there? The answer is no. A growing body of research is revealing another crucial layer to this puzzle, especially in osteoarthritis: the subchondral bone. This is the layer of bone directly beneath the cartilage.

For decades, the conventional wisdom propagated to patients was that osteoarthritis is primarily a disease of cartilage loss. We’ve all heard patients say, “My doctor told me I’m bone on bone” or “My cartilage is gone.” However, we also know that the degree of cartilage loss on an X-ray does not always correlate with the level of pain a person experiences.

So what’s the missing link? It’s often the health of the subchondral bone. When cartilage wears away, the underlying bone is exposed to increased stress and inflammation. This bone is not inert; it’s a living, dynamic tissue rich with blood vessels, nerves, and even a population of stem cells (pericytes) that are vital for healing.

Dr. Philippe Hernigou, a pioneering orthopedic surgeon from France, conducted groundbreaking research on this topic. He compared the number of reparative cells in the iliac crest bone marrow (a common site for harvesting bone marrow) with the number of cells in the subchondral bone of an osteoarthritic knee. His findings were astonishing. As osteoarthritis progressed and patients aged, the concentration of these crucial healing cells in the subchondral bone declined dramatically, whereas levels in the iliac crest remained relatively stable (Hernigou et al., 2013). This suggests that the local healing environment within the knee itself becomes depleted.

This discovery has paved the way for a new and powerful treatment strategy: intraosseous injections. By injecting orthobiologics such as PRP or BMAC directly into the subchondral bone, we can replenish the depleted cellular environment and address the “bone” component of osteoarthritis.

A recent meta-analysis and a consensus statement we published for the American Academy of PM&R have recognized that intraosseous PRP injection has significant merit, particularly for more advanced stages of knee osteoarthritis.
Perhaps the most compelling evidence comes from a pair of sister studies looking at intraosseous BMAC. In one study, patients had one knee replaced and the other treated with an intraosseous bone marrow injection. With an average follow-up of 15 years, over 80% of patients avoided a knee replacement in their treated knee. Remarkably, they overwhelmingly preferred their “bone marrow knee” to their artificial one (Hernigou et al., 2021).
The sister study involved patients who wanted to avoid surgery altogether. They received an intra-articular injection in one knee and an intraosseous injection in the other. Both knees improved, but the knee that received the intraosseous injection had a significantly lower rate of conversion to a total knee replacement (Hernigou et al., 2020).

The takeaway is clear: for severe osteoarthritis, we must look beyond the joint space and the surrounding soft tissues. We must also treat the bone. This is the essence of treating the whole functional unit.

The Art of Diagnosis: How We Decide What to Treat

So, how do we put all this together in a clinical setting? How do we decide which structures to treat? It’s not a matter of just guessing; it’s a combination of deep anatomical knowledge, a thorough physical exam, and the art of clinical reasoning.

This is where we put on our thinking caps. Let’s consider a patient with medial (inner) knee osteoarthritis.

The Exam: A physical exam might reveal a varus deformity (bow-legged stance), which places excessive stress on the medial compartment of the knee.
The Analysis: This varus stress not only compresses the medial meniscus and cartilage but also stretches and weakens structures on the lateral (outer) side of the knee, such as the lateral collateral ligament (LCL).
The Treatment Plan: A comprehensive treatment plan wouldn’t just address the medial joint space. It would also involve treating the LCL to restore stability and correct the biomechanical imbalance that is driving the degeneration.

Conversely, if a patient has a valgus moment (knock-kneed) and lateral compartment arthritis, we would assess the lateral structures as well as the medial ligaments that are being overstretched.

Or consider a case of patellofemoral pain or maltracking, where the kneecap is being pulled laterally. The solution isn’t just to treat the cartilage behind the kneecap. We must ask why it’s being pulled. Often, the medial patellofemoral ligament (MPFL), which acts as a checkrein, is weak or damaged. Treating and strengthening this ligament is key to restoring proper tracking.

Chiropractic Integration: The Bigger Biomechanical Picture

This is where integrative chiropractic care becomes indispensable. The buck doesn’t stop at the knee. We must ask: why did this atraumatic knee issue develop in the first place?

As a chiropractor, I am trained to look at the entire kinetic chain.

Look Distally: We must examine the ankle and foot mechanics. Is there excessive foot pronation causing the tibia to internally rotate, creating a valgus stress at the knee?
Look Proximally: We must evaluate the hip and gluteal muscles. One of the most critical muscles for knee (and hip) stability is the gluteus medius. Weakness in this muscle is a common driver of lower-extremity dysfunction.
Look to the Spine: Could there be a subclinical radiculopathy? A slight nerve impingement in the lumbar spine can cause weakness in key muscles, such as the EHL (the muscle that lifts the big toe), disrupting the entire gait cycle and placing abnormal stress on the knee.

In my practice, I perform detailed muscle strength testing along the kinetic chain, assess for nerve tension, and use chiropractic adjustments to restore proper alignment and nervous system function. By treating only the knee, will we achieve long-term success if the underlying hip weakness or foot dysfunction remains unaddressed? The answer is a resounding no.

By integrating precise orthobiologic injections with comprehensive chiropractic care, physical therapy, and functional medicine principles, we can address the problem from every angle. This is what I mean when I say we must treat the whole person, not just the pain generator. In doing so, we turn the problem into a “treatment generator”—an opportunity to restore health to the entire system.

This is the future of musculoskeletal medicine. It requires us to go back to our roots in anatomy, physiology, and biomechanics, but to apply that knowledge with the most advanced tools and a holistic, integrated mindset. It’s a truly fulfilling way to practice, and it offers our patients the best possible chance for a long-term, functional recovery.

References

Centeno, C. J., Markle, J., Dodson, E., Stemper, I., Williams, C. J., Kisiday, J. D., … & Steinmetz, N. J. (2017). The use of lumbar epidural injection of platelet lysate for treatment of radicular pain. Journal of Experimental Orthopaedics, 4(1), 38. https://dx.doi.org/10.1186%2Fs40634-017-0113-5

Centeno, C., M.D., Pitts, J., M.D., Al-Sayegh, H., M.D., & Freeman, M., D.C., PhD. (2020). Efficacy of autologous, micro-fragmented adipose tissue with leukocyte poor-platelet rich plasma for the treatment of knee osteoarthritis: a randomized controlled crossover study. Journal of Translational Medicine, 18(131). https://doi.org/10.1186/s12967-020-02285-3

Dudley, H. A. F., & White, J. C. (n.d.). Operative Surgery: Fundamental International Techniques.

Hernigou, P., Poignard, A., Beaujean, F., & Rouard, H. (2013). Percutaneous autologous bone-marrow grafting for nonunions. The Journal of Bone and Joint Surgery. American Volume, 87 Suppl 1(Pt 2), 896-903. https://doi.org/10.1302/0301-620X.87B1.15783

Hernigou, P., Bouthors, C., Bastard, C., Flouzat-Lachaniette, C. H., Rouard, H., & Dubory, A. (2021). Subchondral bone marrow concentrate injection is more effective than intraarticular injection in severe osteoarthritis of the knee: a 15-year-follow-up of a randomized controlled trial. International Orthopaedics, 45(2), 341-349. https://doi.org/10.1007/s00264-020-04871-3

Hernigou, P., Delattre, L., Dubory, A., & Flouzat-Lachaniette, C. H. (2020). Intra-articular injection of bone marrow concentrate is a better choice than intra-osseous injection in less advanced osteoarthritis of the knee. International Orthopaedics, 44(7), 1293-1302. https://doi.org/10.1007/s00264-020-04535-2

May 26, 2026

Cardiometabolic Health Solutions With GLP-1 Therapy

Discover the impact of GLP-1 therapy on cardiometabolic health and how it can benefit individuals seeking better wellness.

Abstract: A New Paradigm in Metabolic Health

Welcome to our educational post on the revolutionary class of medications known as GLP-1 receptor agonists. As a practitioner deeply rooted in integrative and functional medicine, with a diverse background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), my primary goal has always been to find the most effective, evidence-based strategies to improve my patients’ health. My clinical observations at our El Paso and San Antonio clinics, coupled with the latest research, continually point toward a more integrated and holistic approach to chronic disease. This post will serve as your guide, translating complex clinical trials and physiological mechanisms into an easy-to-understand narrative. We will delve into how these powerful agents work, explore the landmark cardiovascular outcomes trials (CVOTs) that revealed their ability to protect the heart and kidneys, and differentiate among the available options, such as semaglutide (Ozempic/Wegovy) and the dual-agonist tirzepatide (Mounjaro/Zepbound). Furthermore, we will delve into the practical aspects of using these therapies, including managing side effects, understanding safety considerations, and exploring their investigational uses in everything from neuroprotection to fertility. Most importantly, we’ll connect these pharmacological advancements back to the core principles of integrative health, examining how integrative chiropractic care is essential for maximizing patient outcomes and achieving true, sustainable well-being.

Rethinking Diabetes: Beyond Glucose-Centric Care

In my years of practice, I’ve seen firsthand the devastating impact of diabetes on my patients’ lives. For decades, the management of type 2 diabetes was primarily focused on lowering blood glucose levels. However, we now understand that this is only one piece of a much larger puzzle. It’s a reality underscored by stark statistics. We know that atherosclerotic cardiovascular disease (ASCVD)—which encompasses coronary heart disease, stroke, and peripheral arterial disease—is the leading cause of death for individuals with type 2 diabetes. In fact, more than 70% of elderly patients with diabetes will likely succumb to heart disease or a stroke. The prognosis following a heart attack is significantly poorer for someone with diabetes compared to someone without, and alarmingly, these outcomes often remain bleak even when blood glucose levels are considered “well-controlled.”
This has forced a critical shift in our clinical strategy. The old model, which I call the “glucose-centric” approach, is no longer sufficient. We must move toward a multifaceted management plan that reduces overall risk. This requires a collaborative and integrative effort.

Pillars of Modern Diabetes Management

The world’s leading medical bodies, including the American College of Cardiology (ACC), the American Heart Association (AHA), the American Diabetes Association (ADA), and the Kidney Disease Improving Global Outcomes (KDIGO) group, are all aligned on this new, comprehensive approach. It’s no longer just about the A1c. Our focus must be on:
Lifestyle Management: Foundational changes in diet and physical activity.
Diabetes Self-Management Education: Empowering patients with the knowledge to control their condition.
Cardiovascular Risk Reduction: Aggressively managing blood pressure, cholesterol (lipids), and, of course, glucose levels.
Weight Management: Addressing excess weight as a key driver of metabolic dysfunction.
Smoking Cessation: Eliminating a major accelerator of cardiovascular disease.
This holistic view is the cornerstone of effective, 21st-century care.

Clinical Case Study: The Challenge of “Over-Basalization”

To illustrate these concepts, let’s consider a case similar to many patients I see in my clinic. We’ll call her Naomi.
Naomi is a 66-year-old female who has been living with type 2 diabetes for 12 years. Despite being on a robust medication regimen, her health is not where it needs to be.
A1c: Her last A1c was 8.3%, well above the target of less than 7%.
Comorbidities: She has high cholesterol (hyperlipidemia), hypertension, and protein in her urine (proteinuria), a sign of early kidney stress.
Medications:
Metformin 1000 mg twice daily.
Degludec insulin (a basal insulin): 66 units daily.
An SGLT-2 inhibitor (a class of oral diabetes medication).
A statin for cholesterol.
An ARB for blood pressure.
Weight: She weighs 220 pounds and is 5’9 “, giving her a BMI of 32.5, placing her in the obese category.
Glucose Readings:
Her fasting glucose levels are between 140 and 160 mg/dL. The goal is typically 90-130 mg/dL.
Her postprandial (after-meal) glucose levels are 160-170 mg/dL. While the ADA goal is under 180 mg/dL, many specialists, including myself, prefer to see this number much lower, ideally under 140 mg/dL two hours after a meal.

The Problem: Over-Basalized and Still Not at Goal

Naomi’s case highlights a common clinical problem: “over-basalization.” She is taking a very high dose of basal insulin, yet her A1c and fasting glucose are still too high. A simple clinical calculation I use is to multiply a patient’s weight in kilograms by 0.5. For Naomi, who weighs 100 kg, this suggests that a basal insulin dose above 50 units may be excessive. At 66 units, she is clearly over-basalized.
The high basal insulin dose isn’t effectively controlling her blood sugar, and it’s likely contributing to her difficulty with weight management. The logical next step in a traditional model might be to add prandial (mealtime) insulin to cover her post-meal glucose spikes. However, this is where we can intervene more intelligently. Before adding more insulin, which often leads to further weight gain and increased risk of hypoglycemia, we should consider a GLP-1 receptor agonist. This approach leverages the body’s natural “incretin effect” to address the very issue Naomi is struggling with: postprandial hyperglycemia.

Understanding GLP-1 Receptor Agonists: The Incretin Effect

To truly appreciate these medications and understand why a GLP-1 agent is such a powerful tool, we need to talk about the “incretin effect.” This term describes a fascinating physiological process that is glucose-dependent, meaning these hormones act primarily when glucose is present. Our bodies naturally produce incretin hormones, specifically GLP-1 (Glucagon-Like Peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which are synthesized and released by specialized “L-cells” in the jejunum, a part of our small intestine.
This release is triggered by the presence of food in the gut. When you eat a meal, these hormones are secreted into the bloodstream, orchestrating a multi-pronged response:
Stimulates Insulin Secretion: It signals the pancreas to increase insulin secretion, but only in a glucose-dependent manner. This means it only works when blood sugar is high, dramatically reducing the risk of hypoglycemia compared to insulin or other medications.
Suppresses Glucagon Release: It signals the pancreas to stop releasing glucagon, a hormone that prompts the liver to produce more glucose. This prevents unnecessary glucose from entering the bloodstream.
Slows Gastric Emptying: It slows down the rate at which food leaves the stomach. This makes you feel full sooner and for longer, helping to control appetite and prevent sharp, rapid spikes in blood sugar after meals.
Promotes Satiety: It acts directly on the brain to reduce appetite and increase feelings of fullness.
In individuals with type 2 diabetes, this natural incretin effect is often blunted or, in some cases, completely absent. They produce very low levels of their native GLP-1 hormone. This deficiency leads to insufficient insulin secretion after meals and a failure to suppress glucagon. The result is the hallmark hyperglycemia we see in diabetes. GLP-1 receptor agonists are medications designed to mimic the action of our own GLP-1, but they are engineered to last much longer in the body, restoring and amplifying these beneficial effects.

Mechanisms of Action: More Than Just Blood Sugar Control

The mechanisms of these drugs are multifaceted and explain not only their benefits but also their common side effects.
Gastrointestinal System: In the presence of a GLP-1 agonist, gastric emptying is significantly slowed. This delay is a primary reason patients feel full for longer, which naturally leads to reduced food intake and contributes to weight loss. Unfortunately, this slowing effect can also cause side effects like mild nausea and occasionally vomiting, especially in individuals with a history of gastroparesis. Some patients may experience diarrhea, while others report constipation or mild abdominal pain.
Central Nervous System (Brain): We believe that these small-molecule drugs can cross the blood-brain barrier and act directly on the brain’s appetite centers, such as the hypothalamus. This central action helps to decrease appetite and reduce food cravings, providing another powerful mechanism for weight loss. The feeling of prolonged satiety is likely a combination of this central effect and the delayed gastric emptying.
Pancreas: In the pancreas, GLP-1 agonists stimulate glucose-dependent insulin secretion from the beta cells. Simultaneously, they suppress glucagon secretion. By lowering glucagon, they help reduce the liver’s inappropriate production and release of stored glucose, a common dysfunction in type 2 diabetes.

The “Ominous Octet” and the Power of GLP-1s

In 2009, the renowned endocrinologist Dr. Ralph DeFronzo published a seminal paper describing the “Ominous Octet”—eight core pathophysiological defects that contribute to type 2 diabetes (DeFronzo, 2009). This framework helps us understand the complexity of the disease. What is remarkable is that GLP-1 receptor agonists address six of these eight defects very effectively. Their widespread use makes them among the most comprehensive therapies available.

Choosing the Right GLP-1 Agonist: A Comparative Look

The family of GLP-1 agents has grown, offering us a variety of options with distinct profiles. It’s crucial to choose an agent that aligns with the individual patient’s needs. Let’s look at the data from leading researchers to understand the impact of these medications. When we compare these agents, we see a clear progression in efficacy:
Liraglutide resulted in a weight loss of about 2.7 kilograms and a just under 1% reduction in HbA1c.
Dulaglutide improved upon this, showing an average weight loss of 4.6 kilograms.
Semaglutide represented a significant leap forward, demonstrating an average weight loss of 6.4 kilograms and a more robust HbA1c reduction of between 1.8% and 2.1%.
Then came tirzepatide, a dual GIP and GLP-1 receptor agonist, which has shown truly remarkable results. In clinical trials, it was associated with an average weight loss of 11.2 kilograms—almost double that of semaglutide—and an impressive 2.3% reduction in HbA1c.
It’s crucial to note that these powerful results, particularly for weight loss, were observed at the higher doses approved by the FDA during the drug approval process. Here’s a breakdown of the key players, based on the latest research and FDA indications as of May 21, 2026:
Medication (Brand Name)
Key Indications & Benefits
A1c Lowering
Typical Weight Loss
Semaglutide (Ozempic/Rybelsus)
Type 2 Diabetes, Weight Loss (Wegovy), MACE Reduction, Nephropathy Protection. Semaglutide is a potent agent with robust evidence of cardiovascular and kidney benefits.
~1.5-2.0%
~15% of body weight
Tirzepatide (Mounjaro/Zepbound)
Type 2 Diabetes, Weight Loss, OSA. This is a “twincretin,” a dual GLP-1/GIP agonist, showing the highest efficacy for both glucose lowering and weight loss. Cardiovascular outcome trials are ongoing but look promising.
>2.0%
>20% of body weight
Dulaglutide (Trulicity)
Type 2 Diabetes, MACE Reduction, Nephropathy Protection. A reliable weekly injection with proven cardiovascular and kidney benefits, though with more moderate weight loss compared to newer agents.
~1.0-1.5%
~3-5 kg
Liraglutide (Victoza)
Type 2 Diabetes, MACE Reduction, Nephropathy Protection. One of the first GLP-1s with proven cardiovascular benefits, but it requires a daily injection. Weight loss is more modest. A higher dose is available for weight loss (Saxenda).
~1.1%
~2.5 kg
Exenatide (Byetta/Bydureon)
Type 2 Diabetes. One of the earliest GLP-1s. It is effective for glucose control but has less impact on weight and lacks the proven cardiovascular protection of newer agents.
<1.0%
~2.9 kg
MACE = Major Adverse Cardiovascular Events (heart attack, stroke, cardiovascular death). OSA = Obstructive Sleep Apnea.

When I select a GLP-1 agonist for a patient, I’m not just looking at the A1c. For Naomi, who has hypertension and proteinuria, choosing an agent with proven MACE reduction and nephropathy protection like semaglutide (Ozempic) or dulaglutide (Trulicity) would be a critical part of a comprehensive strategy. Given her significant need for weight loss and A1c reduction, semaglutide or tirzepatide would be the top consideration.

Cardiovascular Outcomes Trials (CVOTs): The Game-Changer

The history of diabetes medications is marked by a pivotal moment in 2008. Following safety concerns with earlier drugs, the FDA mandated that all new diabetes drugs undergo large, long-term Cardiovascular Outcomes Trials (CVOTs). The goal was to demonstrate that these new drugs did not harm the cardiovascular system.
What happened next was completely unexpected and revolutionized our field. Not only were these drugs safe, but they also provided robust cardiovascular risk reduction. This discovery shifted the paradigm from “just diabetes drugs” to essential tools for cardiologists and nephrologists. The GLP-1 receptor agonists soon followed with their own impressive CVOT data:
REWIND Trial (Dulaglutide): Showed a 12% reduction in major adverse cardiovascular events (MACE).
LEADER Trial (Liraglutide): Showed a 13% reduction in MACE.
SUSTAIN-6 Trial (Subcutaneous Semaglutide): Showed a remarkable 26% reduction in MACE.
These large, multi-year, double-blind, placebo-controlled studies involving thousands of patients solidified the role of these medications as cornerstones of cardio-renal-metabolic care. We now view metabolic disease through the lens of the cardio-renal-metabolic (CRM) triad. These systems are bidirectionally linked; a problem in one inevitably affects the others.

How Professional Guidelines Position GLP-1 Agonists

The American Diabetes Association (ADA) has recognized the profound benefits of these medications. The 2025 ADA guidelines, published annually in Diabetes Care, place a strong emphasis on GLP-1 receptor agonists, especially for certain patient populations (ElSayed et al., 2024).
The ADA treatment algorithm is divided into two main pathways:
The Left-Hand Pathway: For patients with established atherosclerotic cardiovascular disease (ASCVD), heart failure, or chronic kidney disease (CKD), or those at very high risk. For these patients, a GLP-1 receptor agonist is now strongly favored as a primary agent, sometimes even before metformin.
The Right-Hand Pathway: For patients whose primary needs are glycemic control and weight management but who do not have the high-risk cardiovascular or kidney profile.
For patients with CKD, SGLT2 inhibitors are often the first choice. However, certain GLP-1 agonists, specifically semaglutide, have also earned an indication for kidney protection. The FLOW trial, stopped early due to overwhelmingly positive results, demonstrated that semaglutide reduced the risk of major kidney disease events and cardiovascular death by 24% in people with type 2 diabetes and CKD.

Balancing Body and Metabolism- Video

Navigating the Switch: A Guide to Changing GLP-1 Agonists

As a clinician committed to patient-centered care, I often encounter scenarios in which a medication switch is considered. A recent case involved a patient, we’ll call her Tammy, who was on Trulicity (dulaglutide) but wasn’t achieving her desired weight loss. Through shared decision-making, we explored a switch. This requires a careful, evidence-informed approach.
Switching from Trulicity (dulaglutide) to Ozempic (semaglutide): To switch from a 1.5 mg dose of dulaglutide, I would begin her on semaglutide 0.5 mg weekly. This conservative start minimizes side effects. After a month, if she tolerates it well, we could increase her to a weekly dose of 1 mg.
Switching from Trulicity (dulaglutide) to Mounjaro (tirzepatide): After her last dose of Trulicity, we would wait a full week (a “washout” period) before starting tirzepatide. I would initiate treatment with tirzepatide 5 mg weekly. The goal is to find the optimal dose—the one where the patient achieves significant satiety and weight loss with minimal side effects—by titrating up every four weeks if needed.

The Expanding Universe of GLP-1 Receptor Agonists

The story of GLP-1 agonists is no longer confined to diabetes. The research community is buzzing with discoveries about their far-reaching benefits.

Metabolically Associated Steatotic Liver Disease (MASLD)

One of the most promising frontiers is in liver health. The primary benefit for MASLD and its inflammatory progression, MASH, comes from the significant and sustained weight loss these drugs induce, which directly decreases fat deposition in the liver (Abbasi, 2024). Novo Nordisk is seeking FDA approval for this indication, which we may see by late 2025 or early 2026.

Expanding Indications: Beyond Diabetes

The benefits have proven to extend beyond patients with type 2 diabetes, as established by two landmark trials:
STEP-HFpEF Trial: This study showed that in patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide led to significant improvements in heart failure symptoms and physical limitations, regardless of whether the patients had diabetes (Kosiborod et al., 2023).
SELECT Trial: This trial involved over 17,000 overweight or obese patients with pre-existing heart disease but without diabetes. The group receiving semaglutide showed a 20% reduction in MACE compared to placebo.

Cravings, Compulsive Behaviors, and Addiction

A consistent report from my own patients is a dramatic reduction in cravings. They describe it as a quieting of the constant “food noise” in their brain, with a decreased desire for alcohol and smoking. This points to a fundamental impact on the brain’s reward pathways.

PCOS, Fertility, and the “Ozempic Babies” Phenomenon

For many women with Polycystic Ovary Syndrome (PCOS), the substantial weight loss from these drugs can restore metabolic balance and regulate menstrual cycles. This has led to enhanced fertility and the recent media phenomenon of “Ozempic babies.”

Other Investigational Uses

Researchers are also observing positive effects in:
Neuroprotection: Patients with dementia and Parkinson’s disease have shown a stall in disease progression, suggesting a neuroprotective effect within the brain.
Latent Autoimmune Diabetes in Adults (LADA): The off-label use of GLP-1 agonists is being studied to help preserve remaining beta-cell function in this form of autoimmune diabetes (Buzzetti et al., 2020).
Respiratory Health: In patients with asthma and COPD, these drugs have been associated with fewer exacerbations, likely due to their anti-inflammatory properties.

The Role of Integrative Chiropractic Care

This is where my perspective as a DC, APRN, and Functional Medicine Practitioner becomes so important. While these medications are incredibly powerful, they are tools, not cures. True, lasting health is achieved when we combine these advanced pharmacotherapies with a foundation of lifestyle and structural wellness.
Optimizing Nervous System Function: The nervous system is the body’s master controller. The gut-brain axis is a two-way communication highway critical for satiety signaling. Chiropractic adjustments can help reduce nerve interference, potentially enhancing the body’s response to these signals and improving the efficiency of the gut-brain connection.
Supporting Musculoskeletal Health During Weight Loss: Rapid and significant weight loss can place new stresses on the body as a patient’s center of gravity shifts. This can lead to new patterns of musculoskeletal pain. Integrative chiropractic care is crucial for managing these biomechanical changes through targeted adjustments, soft-tissue work, and the prescription of corrective exercises.
Addressing the Root Causes: Functional medicine teaches us to ask “Why?” We use a holistic approach to craft personalized nutrition plans, develop sustainable exercise regimens that preserve muscle mass, and implement stress-management techniques to reduce cortisol levels.
Chiropractic care is not an alternative to these medications; it is a vital complement. By ensuring the body’s structure and nervous system function optimally, we create an environment in which these powerful drugs can work most effectively.

Safety, Side Effects, and Practical Recommendations

While transformative, these medications require careful management.

Common GI Side Effects

Nausea: This is the most common side effect, often linked to early satiety.
Constipation or Diarrhea: The effect on motility varies by individual.
Management Strategy: The key is to “start low and go slow.” I start patients on the lowest possible dose for at least a month before considering an increase.

Important Safety Issues

Gallbladder Events: Rapid weight loss can increase the risk of gallstones.
Acute Kidney Injury: Can occur from severe nausea and vomiting leading to dehydration. Staying well-hydrated is critical.
Pancreatitis: Though rare, patients with severe, persistent abdominal pain should seek immediate medical attention.
Surgical Considerations: Anesthesiology guidelines recommend stopping weekly GLP-1 agonists at least one to two weeks before a planned surgery to reduce the risk of aspirating stomach contents.
Muscle and Bone Mass: Significant weight loss involves some loss of lean muscle and bone. I work with patients to incorporate resistance training and ensure adequate protein intake.

Black Box Warning: Thyroid C-Cell Tumors

These medications carry a black box warning regarding the risk of thyroid C-cell tumors observed in rodent studies. While this link has not been established in humans, the drugs are contraindicated in patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Final Thoughts: A New Hope for Patients

The advent of modern GLP-1 receptor agonists has fundamentally changed the landscape of diabetes and metabolic care. For patients like Naomi, starting a GLP-1 agonist is not just about adding another medication; it’s about shifting her disease trajectory. It offers the potential to achieve her A1c goal, lose significant weight, reduce her reliance on insulin, and lower her risk of a future heart attack or stroke.
As healthcare providers, it is our responsibility to embrace a comprehensive, integrative approach. By combining the power of these advanced medications with the foundational principles of lifestyle medicine and chiropractic care, we can offer our patients a new level of hope and empower them to achieve a healthier, more vibrant future.

References

SEO Tags: GLP-1 agonists, Semaglutide, Tirzepatide, Ozempic, Mounjaro, Wegovy, Zepbound, Type 2 Diabetes, Weight Loss, Cardiovascular Risk Reduction, Integrative Chiropractic Care, Functional Medicine, Dr. Alexander Jimenez, El Paso Chiropractor, A1c, Postprandial Glucose, Incretin Effect, Metabolic Health, Heart Health, Kidney Disease, CVOT, Ominous Octet, Gastric Emptying, Satiety, MASH, neuroprotection, PCOS, fertility, LADA, patient-centered care, cardio-renal-metabolic health, chiropractic adjustment, musculoskeletal health

May 4, 2026

Bioidentical Hormone Therapy for Energy and Wellness

Abstract

In this educational post, I will explore the transformative potential of Bioidentical Hormone Replacement Therapy (BHRT), focusing on its role in vitality, longevity, and overall quality of life. As a practitioner with a diverse background in chiropractic (DC), nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), I approach patient care through a holistic and integrative lens. We will journey through the physiological underpinnings of hormonal balance, covering the nuances of therapy for both men and women, including key considerations like family planning, menopause, and polycystic ovary syndrome (PCOS). I will detail the evolution of hormone pellet therapy toward a modern, atraumatic approach, explaining the procedural details that ensure patient safety and comfort. Furthermore, I will explain how integrative chiropractic care plays a crucial role in this holistic model by supporting the body’s musculoskeletal and neurological systems, thereby enhancing the benefits of hormonal optimization. Our goal is to empower you with knowledge, clarifying the science behind hormone replacement and helping you understand the path to renewed health.

Hello, I’m Dr. Alexander Jimenez. My work is rooted in a deep passion for understanding the body as an interconnected system. With credentials spanning from Doctor of Chiropractic (DC) and Advanced Practice Registered Nurse (APRN) to certifications in Functional Medicine (CFMP, IFMCP), I have dedicated my career to integrating various healing modalities to achieve optimal patient wellness.

In my practice, we frequently see individuals whose lives are compromised by hormonal imbalances. They come to us with symptoms ranging from fatigue and brain fog to weight gain and low libido. They are looking for a sustainable path to wellness, not just a temporary fix. This is the revolution I see—a demand for a better quality of life, driven by a desire to feel and function at one’s best. By leveraging the latest evidence-based research from leading experts, we can offer solutions like bioidentical hormone replacement therapy (BHRT), which can be truly transformative when approached correctly.

BHRT and Family Planning: A Critical First Step

One of the first and most critical conversations I have with patients considering BHRT revolves around their family planning goals. This is a non-negotiable starting point because hormone therapy directly influences the reproductive system.

For Men: Preserving Fertility: If a man tells me he and his partner are planning to have children in the near future, testosterone therapy is immediately off the table. Introducing external testosterone sends a signal to the brain’s pituitary gland to stop producing two key hormones: Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). These hormones are essential for testicular function. When their production ceases, the testes stop producing their own testosterone and, crucially, sperm production plummets. This effectively renders the man temporarily infertile. While fertility typically returns after stopping therapy, it’s a risk we cannot take if a couple is actively trying to conceive. The conversation is simple: “When are you planning to have children?” If the answer is within the next few years, we explore other avenues.
For Women: Navigating Contraception and Intentions: The conversation with women is equally nuanced. A woman’s use of birth control is a significant factor, as it signals a conscious decision not to conceive. This allows us to work more freely with her hormonal state to alleviate other symptoms. However, we always clarify long-term intentions. The fundamental principle is that we must align our treatment with the patient’s life goals. Fertility is a precious biological function, and we must protect it with informed and responsible care.

Hormone Therapy for Women: Navigating Menopause and Beyond

The vast majority of women I see for BHRT are either perimenopausal (the transition years leading up to menopause) or postmenopausal. These are the stages where hormonal support can offer the most significant benefits.

Postmenopausal Women: For women who are postmenopausal—defined as having gone 12 consecutive months without a menstrual period—BHRT is often a game-changer. They are no longer concerned with menstrual cycles, making hormonal management more straightforward. It can feel like the best time of their lives once we restore balance.
Hysterectomy Patients: A common question is whether women who have had a hysterectomy can benefit from BHRT. The answer is a resounding yes. Most modern hysterectomies involve the removal of the uterus, but the ovaries—the primary producers of estrogen and progesterone—are often left in place. However, if a woman has had a radical hysterectomy where the ovaries were also removed (an oophorectomy), she is plunged into immediate surgical menopause. In these cases, BHRT is essential, as removing the ovaries without replacing their hormones has been linked to accelerated bone density loss, cognitive decline, and other health risks (Shifren & Gass, 2014).
Understanding Progesterone and Spotting: When we reintroduce hormones, particularly in perimenopausal women, spotting can occur. This is almost always related to fluctuations in progesterone, which stabilizes the uterine lining. When progesterone levels drop, the lining breaks down, causing bleeding. In BHRT for a woman with a uterus, we sometimes strategically stop progesterone to trigger a “withdrawal bleed.” This safely sheds the uterine lining, preventing a condition called endometrial hyperplasia, a risk factor for cancer. This is a controlled and necessary part of a safe, long-term BHRT protocol.

A Paradigm Shift in Pellet Insertion Technology

In my years of clinical practice, I have always sought advancements that prioritize patient safety and comfort. One of the most exciting developments is in the field of hormone pellet therapy, specifically in moving from traditional, traumatic methods to a modern, atraumatic approach.

Simplified, Superior Design: We are moving away from older, multi-piece trocars that relied on a sharp, cutting tip. Today’s modern trocar has a simplified two-piece design, but the crucial innovation is its blunt, conical tip. This tip is engineered not to cut tissue, but to gently separate and dilate it.
The “Laying” vs. “Plunging” Method: This new design facilitates a gentler procedure. Instead of forcefully “plunging” pellets into the tissue, we now gently “lay” them into the subcutaneous tract created by the trocar.

The physiological rationale is profound. By separating tissue fibers instead of severing them, we drastically reduce damage to the surrounding microvasculature. This minimizes the initial injury and the subsequent inflammatory cascade. Less trauma means less release of inflammatory mediators, leading to significantly less post-procedural pain, swelling, and risk of complications like hematomas. This atraumatic approach aligns with the core medical principle of “primum non nocere”—first, do no harm.

Mastering the Female Pellet Insertion: Precision and Patient Comfort

The execution of a female pellet insertion has been refined to a science. The primary location is the upper outer quadrant of the gluteal area, a region rich in fatty tissue ideal for the slow release of hormones.

Anatomical Landmarkings: The “Goldilocks” Principle

Finding the perfect spot for insertion is what I call the “Goldilocks” principle—it must be just right.

Avoiding the IT Band: Placing pellets too far laterally, near the iliotibial (IT) band, can cause significant pain. The IT band is a thick, fibrous fascial band, and placing pellets near it can cause friction and inflammation with every movement.
Steering Clear of the Coccyx: Placement too low or medial, approaching the gluteal cleft and coccyx (tailbone), is also problematic due to pressure when sitting and an increased risk of infection.
Respecting the “Tan Line”: A practical yet important consideration is to keep the incision within the typical bikini line to maintain patient confidence.

To achieve this precision, I use the lidocaine syringe and needle as a measuring tool. The needle length matches the trocar. By placing the needle tip where I want the pellets to rest, I can lay it back to see exactly where the hub lands. This marks the ideal location for the incision, ensuring pellets are deposited in the desired fatty pocket, far from sensitive structures.

The Atraumatic Insertion Procedure: A Step-by-Step Guide

With the patient properly positioned and the area anesthetized, the insertion itself is swift and precise.

Creating the Perfect Lidocaine “Wheal”: Anesthesia is key to patient comfort. The procedure begins by inserting the needle just under the epidermis and injecting a small amount of lidocaine to create a visible, blanched bubble on the skin called a wheal. This is the gateway to a painless procedure.
Anesthetizing the Tract: After the wheal is formed, I advance the needle along the predetermined path at a 45-degree angle, injecting lidocaine continuously as the needle advances and as it is withdrawn. This bathes the entire subcutaneous pathway in anesthetic, ensuring the deeper fatty tissue is numb.
Aseptic Technique: We adhere to aseptic procedures using sterile instruments. We meticulously clean the skin with a chlorhexidine gluconate (ChloraPrep) solution, which provides a more robust and longer-lasting antimicrobial effect than alcohol (Lim & Kam, 2008).
The Incision and Trocar Introduction: Using a #11 scalpel blade, I make a tiny incision. I then “bury” the trocar’s conical tip and, with a gentle, wiggling motion, advance it through the anesthetized tract.
Laying the Pellets: Once the trocar is in place, I remove the inner stylet and carefully place the prescribed pellets into the trocar’s chamber. Then, I re-insert the stylet until it contacts the pellets. At this point, I do not plunge. Instead, I firmly hold the inner stylet in place to anchor the pellets and smoothly retract the outer cannula. This action gently “lays” the pellets in a neat stack within the tissue, eliminating traumatic force.

The difference is immediately visible. With this atraumatic technique, the incision site is remarkably clean, with minimal to no oozing—a clear clinical indicator that we have preserved tissue integrity.

The Lifespan of Pellets: Cardiac Output as a Key Determinant

A common question is, “How long will the pellets last?” The answer is intricately linked to an individual’s physiology, specifically their metabolic rate, which we can assess through cardiac output.

Cardiac output is the total volume of blood your heart pumps per minute, calculated as:

Cardiac Output = Stroke Volume x Heart Rate

A higher cardiac output means blood is circulating more rapidly, and hormones delivered via pellets are metabolized, or “burned through,” at a faster rate.

Sedentary Individuals: Someone with a lower cardiac output will metabolize hormones more slowly, so the pellets may last closer to 4 or even 5 months.
Athletes and Highly Active Individuals: In contrast, those with a high cardiac output are metabolic powerhouses and may burn through their pellets in as little as two to three months.

This variability is normal. At the Chiropractic & Functional Medicine Clinic, we closely monitor each patient’s symptoms to determine the optimal timing for follow-up treatments, ensuring a steady, optimal hormonal state.

Testosterone Therapy: The Advantage of Pellets Over Injections

When it comes to testosterone replacement, the delivery method matters immensely. I strongly advocate for bioidentical hormone pellets over injections for long-term health.

Injections and Testicular Atrophy: Testosterone injections flood the body with a large, supraphysiological dose, creating a “roller coaster” of peaks and troughs. This powerful signal tells the brain to almost completely shut down its own production signals (LH and FSH). Over time, this leads to significant testicular atrophy—the testicles shrink and may permanently lose function (Swerdloff & Wang, 2020).
The Pellet Advantage: Hormone pellets release a small, steady, physiologic dose over several months, mimicking the body’s natural output. While there is still some minor suppression of natural production, it is far less dramatic and damaging. Function is preserved to a much greater degree, making pellets a safer and more physiologically sound option for long-term therapy.

Integrative Chiropractic Care: A Holistic Framework for Hormonal Health

As a Doctor of Chiropractic, I view the body as an interconnected system. Hormonal balance is not just a chemical state; it is deeply intertwined with our neurological and musculoskeletal health. This is where integrative chiropractic care becomes an invaluable partner to BHRT.

Addressing the Root Cause: Chiropractic adjustments can help restore proper nervous system function by correcting spinal misalignments (subluxations). A well-functioning nervous system is essential for the hypothalamic-pituitary-adrenal (HPA) axis, the master controller of hormone production. By optimizing neurological pathways, we help the body better regulate its own endocrine functions.
Supporting Musculoskeletal Recovery: As hormone therapy restores muscle mass and improves tissue quality, chiropractic care ensures the body’s framework can support these changes. Adjustments and soft-tissue work can address compensatory patterns, improve posture, and reduce biomechanical stress.
Breaking the Cycle of Pain and Inactivity: A patient with chronic back pain is often trapped in a cycle: pain leads to inactivity, which causes muscle atrophy, which destabilizes the spine and worsens pain. BHRT helps rebuild atrophied muscle, while chiropractic care addresses the structural source of the pain. Together, they break the cycle, allowing a return to an active, pain-free life.
Preventing Future Degeneration: Strong muscles are the best defense against joint degeneration and arthritis. Research has consistently shown that strong supporting musculature reduces joint load and can slow the progression of osteoarthritis (Goh et al., 2019). By using BHRT to build that muscle and chiropractic care to ensure proper joint mechanics, we are actively working to prevent the chronic diseases of aging.

My clinical observations consistently show that patients who receive concurrent chiropractic care alongside their hormone therapy report faster symptomatic relief, improved physical function, and a greater overall sense of well-being. This integrated approach ensures we are not just replenishing a hormone but restoring the entire system to optimal function.

Post-Procedure Care and Closure: Ensuring Optimal Healing

Proper closure of the incision and clear patient instructions are the final, critical pieces of the puzzle.

Approximating the Wound: We use a Steri-Strip, but its application is key. I apply one side, gently pinch the skin edges together to approximate them, and then pull the strip taut to hold the wound closed.
The Pressure Bandage: Over the Steri-Strip, a folded gauze pad acts as a pressure bandage when taped down securely. This pressure minimizes the risk of a hematoma.
Patient Instructions: Clear communication is essential.
- The inner Steri-Strip should remain in place for at least three days, ideally until it falls off naturally.
- The outer pressure bandage can be removed later the same day or the following morning.
- For at least three days, patients must avoid soaking the area (no hot tubs or baths) and refrain from excessive glute-flexing exercises to allow the site to heal.

By following this meticulous, evidence-based protocol, we elevate the standard of hormone pellet therapy, transforming it into a refined clinical art that prioritizes patient comfort, safety, and superior long-term outcomes. This is a fundamental shift from a disease-management model to a wellness-and-longevity model, empowering you to live a life free from the limitations of pain and chronic illness.

References

Goh, S. L., Persson, M. S., Stocks, J., Hou, Y., Lin, J., Hall, M. C., Doherty, M., & Zhang, W. (2019). Efficacy and potential determinants of exercise therapy in knee and hip osteoarthritis: A systematic review and meta-analysis. Annals of Physical and Rehabilitation Medicine, 62(5), 356–365.

Lim, K. S., & Kam, P. C. A. (2008). Chlorhexidine—pharmacology and clinical applications. Anaesthesia and Intensive Care, 36(4), 502–512.

Shifren, J. L., & Gass, M. L. S. (2014). The North American Menopause Society statement on management of symptomatic vulvovaginal atrophy. Menopause, 21(11), 1145–1162.

Swerdloff, R. S., & Wang, C. (2020). The testis and male hypogonadism, infertility, and sexual dysfunction. In S. Melmed, R. J. Auchus, A. B. Goldfine, R. J. Koenig, & C. J. Rosen (Eds.), Williams Textbook of Endocrinology (14th ed., pp. 646-724). Elsevier.

April 24, 2026

BHRT: What to Expect With Hormones & Pellet Therapy

Understand the impact of BHRT and pellet therapy on your hormonal health and how they can improve your quality of life.

Abstract

Hello, I’m Dr. Alexander Jimenez. Welcome to this educational exploration of hormone health and integrative care. In my practice, which combines chiropractic care with advanced functional and integrative medicine, I have seen firsthand the profound impact hormonal balance has on overall health. This post is designed to guide you through the sophisticated, evidence-based approaches we use to manage hormonal imbalances, particularly those associated with perimenopause, menopause, and andropause. We will begin by outlining the streamlined patient journey in our clinic, from initial contact to follow-up care, highlighting the use of modern tools, such as QR code campaigns, to enhance patient education. Following this, we will dive into detailed case studies of both a female and a male patient. Through these real-world examples, I will break down the interpretation of comprehensive lab work, discussing key biomarkers like ferritin, thyroid-stimulating hormone (TSH), free testosterone, and Estradiol. We’ll explore the physiological significance of these markers and how they inform our treatment decisions, including the use of Bioidentical Hormone Replacement Pellet Therapy (BHRT). I will also detail the precision of the pellet insertion procedure itself and discuss the critical role of integrative chiropractic care in addressing the musculoskeletal and neurological symptoms that often accompany hormonal shifts. Our goal is to present a holistic, patient-centered model that combines cutting-edge research with personalized clinical care to optimize health and well-being.

Revolutionizing the Patient Experience: A Streamlined Clinical Workflow

Over my years in practice, I’ve observed a significant paradigm shift in how we approach patient care, especially in the realm of hormonal health. The journey to wellness must be clear, efficient, and supportive. I want to walk you through the workflow we have refined in our clinics, which serves as a roadmap for both our patients and our providers.
Our process begins the moment a potential patient expresses interest.

Initial Contact and Lab Initiation: When someone calls our office, we schedule them for an initial provider consultation. Critically, we don’t wait for that first appointment to start gathering information. We immediately initiate a comprehensive lab panel tailored to their likely needs. This proactive step ensures that when I first sit down with a patient, we have objective data to guide our conversation.
Empowering Through Education: The QR Code Campaign: About 13 years ago, working with a business coach, I had a realization: we were repeating the same foundational information to every new patient. While necessary, it consumed valuable consultation time that could be better spent on a personalized strategy. This led to the creation of our QR code educational campaigns. Before their first visit, patients receive access to a series of short, digestible videos. These videos answer common questions about hormone therapy, explain the process, and demystify the science. By the time they come in to review their labs, they are already educated and empowered, allowing us to have a much deeper and more productive conversation.
The Comprehensive Consultation: During the consultation, we review several key items together:
- Symptom Checklists: We use validated tools such as the Menopausal Rating Scale (MRS) and our Bioidentical Hormone Replacement Therapy (BHRT) symptom checklist.
- Lab Results: We conduct a thorough, line-by-line review of their comprehensive lab work.
- Treatment Options: We discuss all available treatment modalities. In our office, this includes pellets, injections, and creams. We present the pros and cons of each, allowing the patient to make an informed choice that aligns with their lifestyle and preferences.

Once a treatment plan is decided upon, we schedule the procedure. Before they leave, we also schedule their follow-up lab work. In the early days, we used to tell patients to come back when they “felt” their symptoms returning. This was a mistake. The decline is often so gradual that patients don’t recognize it until they feel significantly unwell again, leading to poor retention and inconsistent results. Now, we pre-schedule follow-up labs—typically at 14 weeks for women and 18 weeks for men—to stay ahead of the curve and maintain optimal levels. This proactive approach is key to long-term success.

The Critical Role of Informed Consent and Patient Education

In medicine, documentation is paramount. The informed consent process is not merely a legal formality to protect the practitioner; it is a cornerstone of ethical care that justifies and explains the entire treatment plan. Our consent forms are comprehensive educational documents. They explicitly detail why we believe in BHRT and reference the scientific literature supporting its use. We are transparent about the off-label nature of custom-compounded hormone pellets. While the hormones themselves (testosterone, estradiol) are FDA-approved, their use in the form of compounded pellets for indications such as improving well-being and mitigating age-related symptoms is considered off-label.
The consent form explains the rationale for using pellets, the specific labs and diagnostic criteria used, potential side effects, and the critical importance of adherence. By having the patient read and sign this detailed document, we ensure they can never say, “I was never told.” This level of transparency builds trust and protects both the patient and the provider.

Case Study 1: Decoding Menopausal Symptoms in a 59-Year-Old Female

Let’s delve into a representative case to see how this process plays out. This patient is a 59-year-old female presenting with common complaints associated with post-menopause.
Her Menopausal Rating Scale (MRS) reveals a significant symptom burden. The scale, which is numerically scored, shows she is experiencing severe symptoms, particularly in the realms of mood (depressive symptoms) and sexual health (diminished desire). Her score is far from the ideal post-treatment goal. This subjective data is our starting point; it’s the patient’s lived experience.

Comprehensive Lab Analysis: Uncovering the Root Causes

Next, we turn to her objective lab data. A full understanding requires looking beyond just the sex hormones.

Ferritin: Her ferritin level is a point of concern. Ferritin is the body’s primary iron storage protein. A low ferritin level, even if hemoglobin and hematocrit are normal, can mimic and exacerbate symptoms of hormonal imbalance, such as fatigue, hair loss, and brain fog. Before initiating hormone therapy, it is crucial to optimize iron stores. In her case, I would recommend a daily dose of a high-quality iron supplement.
Vitamin D: Her Vitamin D level is also suboptimal. Vitamin D, a pro-hormone, is essential for immune function, bone health, and mood regulation. Research, such as that highlighted by Holick (2007), underscores its systemic importance. For a patient like this, I would typically start with a dose of 5,000 IU daily to bring her levels into the optimal range, which can also help mitigate inflammatory processes.
Thyroid Panel:
- Her Thyroid-Stimulating Hormone (TSH) is 3.8 mIU/L. While this may fall within a “normal” lab reference range, the functional and anti-aging medicine communities, supported by a growing body of literature, advocate for a much narrower optimal range, typically below 2.5 mIU/L (Jabbar et al., 2021). A TSH of 3.8 suggests her thyroid is working too hard, a sign of subclinical hypothyroidism.
- Her Free T3 is suboptimal. T3 is the active thyroid hormone that drives metabolism in every cell of the body.
- Her Free T4 is 0.8 ng/dL. This is also on the low end of the optimal range.

My immediate thought is that her thyroid is sluggish. The brain’s pituitary gland is releasing more TSH to “yell” at the thyroid, which is under-responding. This is a classic feedback loop issue that contributes significantly to her fatigue, weight gain, and depressive mood.

Sex Hormones:
- Her Free Testosterone is functionally zero. This is a critical finding. While often considered a “male” hormone, testosterone is vital for women’s energy, mood, cognitive function, muscle mass, and libido. A level this low is a primary driver of her symptoms.
- Her Estradiol is 18 pg/mL. For a post-menopausal woman, this isn’t dangerously low, but it’s far from optimal for symptom relief and protection against bone loss and cognitive decline. Research by Santoro, Roeca, and Peters (2021) clearly outlines the systemic effects of estrogen decline. The brain is literally starving for these hormones.

The Treatment Plan: BHRT and Integrative Chiropractic Care

Based on these findings, this patient is a clear candidate for Bioidentical Hormone Replacement Pellet Therapy (BHRT). My goal is to restore estradiol and testosterone to levels reminiscent of her pre-menopausal state, where she felt her best. This is not about achieving supra-physiological levels but about restoring physiological balance.
This is also where integrative chiropractic care becomes essential. Hormonal decline, particularly the loss of estrogen and testosterone, directly impacts musculoskeletal integrity.

Musculoskeletal Support: Patients often report new aches, joint stiffness, and a sense of physical fragility. The “meno-belly” she describes—a sudden accumulation of visceral fat around the midsection despite no changes in diet or exercise—is a classic sign of hormonal shift, driven by cortisol and insulin dysregulation secondary to low estrogen. Chiropractic adjustments help restore proper joint mobility and alleviate pain. We also incorporate specific soft tissue therapies to address muscle tension and fascial restrictions that develop.
Neurological Regulation: The nervous system and endocrine system are intricately linked. Spinal misalignments can interfere with the signaling of the hypothalamic-pituitary-adrenal (HPA) axis, which governs our stress response and hormone production. By performing targeted chiropractic adjustments, we can help normalize neurological feedback loops, reduce sympathetic (fight-or-flight) overdrive, and support the body’s overall ability to adapt and heal. This is particularly important for managing the anxiety and sleep disturbances that accompany menopause.

For this patient, the plan is multifaceted: initiate BHRT to address foundational hormonal deficiencies; supplement to correct her vitamin D and ferritin levels; provide nutritional guidance to support her thyroid and manage inflammation; and implement regular chiropractic care to address the structural and neurological consequences of her hormonal state.

Assessing Hormone Therapy- Video

Case Study 2: Addressing Andropause in a Male Patient

Now, let’s consider a male patient presenting with symptoms of andropause, the male equivalent of menopause. He reports a classic constellation of symptoms on the Aging Male Symptoms (AMS) scale: low libido, decreased stamina, loss of morning erections, increased visceral fat (a “pot belly”), and general GI issues.

Interpreting the Male Lab Panel

His lab work paints a stark picture of metabolic and hormonal decline.

Kidney Function: His elevated creatinine is an immediate flag for impaired kidney function. My first step is to educate him on this finding and ensure he follows up with his primary care provider or a nephrologist. We must work collaboratively and ensure all aspects of a patient’s health are monitored.
Bone Density: He has signs of osteopenia. I would educate him about the importance of a DEXA scan to get a precise measure of his bone mineral density. Testosterone is crucial for maintaining bone health in men, and its decline is a major risk factor for osteoporosis (Mohamad et al., 2016).
Metabolic Markers:
- His Hemoglobin A1c indicates prediabetes.
- His C-Reactive Protein (CRP), a marker of systemic inflammation, is elevated.
- He has hypertension and high cholesterol.
Sex Hormones:
- His Total Testosterone is 122 ng/dL. This is profoundly low. Optimal levels for a man should be in the 700-900 ng/dL range. A level of 122 is not just a quality-of-life issue; it is a medical issue that drives his metabolic disease. Low testosterone is directly linked to an increased risk of diabetes, heart disease, and cognitive decline.
- His Sex Hormone-Binding Globulin (SHBG) is very low. SHBG is a protein that binds to testosterone, making it unavailable to the tissues. While a low SHBG might seem good because it means more “free” testosterone is theoretically available, in the context of his overall metabolic dysfunction, it’s another sign of insulin resistance and inflammation.

The Comprehensive Treatment Protocol for Andropause

This patient is a prime candidate for Testosterone Pellet Therapy. Restoring his testosterone to an optimal physiological range is the single most effective intervention to address the root cause of his myriad symptoms. As with our female patient, integrative chiropractic care is a cornerstone of his treatment. Low testosterone is associated with sarcopenia (age-related muscle loss) and joint pain.

Biomechanical Optimization: We use chiropractic adjustments to ensure his spine and extremities are functioning optimally, providing a stable foundation for the renewed exercise and physical activity that testosterone therapy will enable.
Pain Management: We address the chronic aches and pains that have likely made him more sedentary, creating a vicious cycle of inactivity and further decline.
Lifestyle Coaching: As part of our integrative model, we provide targeted advice on resistance training and nutrition to maximize the benefits of his hormone therapy, helping him rebuild muscle, lose fat, and reclaim his vitality.

By combining cutting-edge BHRT with foundational chiropractic care and lifestyle medicine, we can dramatically alter the trajectory of his health, moving him from a state of metabolic disease and low vitality to one of optimal function and well-being.

The Art and Science of Pellet Insertion Technique

The physical procedure of pellet insertion has evolved significantly. The technique used is just as important as the dosage itself, as it directly impacts hormone absorption, efficacy, and patient comfort. We have moved far beyond outdated methods that caused unnecessary trauma and inconsistent results. Today, we use a much more elegant and effective no-scalpel, micro-tunneling technique that prioritizes precision and minimizes tissue trauma.

Preparation and Anesthesia: After preparing a sterile field, we use a two-step numbing process to anesthetize the deep fatty layer of the upper gluteal region, well above the muscle.
The Incision and Trocar: A tiny incision is made parallel to Langer’s lines (natural skin tension lines) to promote better healing and minimize scarring. We then use a specialized blunt-tipped instrument called a trocar to gently separate the fatty tissue and create small, separate tunnels or “tracks”. This avoids cutting through tissue, which reduces trauma and bleeding.
Layered Pellet Placement: We carefully lay the pellets down in these individual tracks, fanning them out like the spokes of a wheel. This technique is revolutionary because it maximizes the surface area for neovascularization—the formation of new blood vessels. These tiny capillaries grow around each pellet, creating a rich vascular network that ensures slow, steady, and consistent hormone absorption over several months.
Bandaging for Optimal Healing: We close the small incision with Steri-Strips to approximate the wound edges, then apply a multi-layered dressing. This includes a sterile gauze pad, a protective “T” formation with medical tape to prevent accidental removal, and a final waterproof bandage. This meticulous process is designed to promote rapid healing and prevent complications.

Proper post-procedural care, including keeping the area dry and avoiding strenuous activity for several days, is essential to prevent infection and ensure the best possible outcome.

Follow-Up and Long-Term Management: The Art of Titration

Hormone therapy is a dynamic process, not a one-size-fits-all-for-life solution. The goal of the first round of pellets is to fill the patient’s “empty tank.” Subsequent rounds are about maintenance and fine-tuning. After about four to six weeks, we re-check labs. I often see cases where a patient feels “amazing,” but their lab values haven’t reached our definition of the optimal range. This tells me we can further optimize their dose for even better, longer-lasting results.
Conversely, a patient will not require the same large initial dose for their second round. Continuing to give the same high dose would eventually lead to symptoms of excess. This is where clinical acumen comes into play. We must listen to the patient’s subjective experience and titrate their dose based on a combination of their symptoms and lab values. This is a partnership. By managing expectations and adjusting the course as needed, we can guide our patients toward vibrant health and a dramatically improved quality of life.

References

Guo, S., & DiPietro, L. A. (2010). Factors affecting wound healing. Journal of Dental Research, 89(3), 219–229.
Holick, M. F. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266–281.
Jabbar, A., Ingoe, L., Pearce, S., Zaman, A., & Razvi, S. (2021). Thyroxine treatment for subclinical hypothyroidism: a clinical practice guideline. European Thyroid Journal, 10(2), 152–162.
Mohamad, N. V., Soelaiman, I. N., & Chin, K. Y. (2016). A concise review of testosterone and bone health. Clinical Interventions in Aging, 11, 1317–1324.
Santoro, N., Roeca, C., & Peters, B. A. (2021). The menopause transition: Signs, symptoms, and management options. The Journal of Clinical Endocrinology & Metabolism, 106(1), 1–15.
Schaffer, C. J., Nanney, L. B., & Stecenko, A. A. W. H. (2016). Wound healing. In Fitzpatrick’s Dermatology in General Medicine (9th ed.). McGraw-Hill.
Yoo, J. Y., Groer, M., Dutra, S. V. O., & Sarkar, A. (2020). Gut microbiota and immune system interactions. Microorganisms, 8(10), 1587.

SEO Tags: Hormone Replacement Therapy, BHRT, Bioidentical Hormones, Menopause, Andropause, Integrative Chiropractic Care, Functional Medicine, Testosterone, Estradiol, Thyroid Health, Dr. Alex Jimenez, Pellet Therapy, Subclinical Hypothyroidism, Ferritin, Vitamin D, Patient Education, Clinical Workflow, Case Study, Pellet Insertion, Wound Healing, Langer’s Lines, Trocar Technique, Musculoskeletal Health, Inflammation, El Paso Chiropractor

December 8, 2025

Pain Management Approaches for Patients in a Clinical Setting

Master the art of pain management in a clinical setting with innovative strategies to support those suffering from pain in healthcare environments.

Understanding Pain: Causes, Categories, and Effective Management Strategies

Pain is something that everyone goes through, and it can range from mild to severe. It affects millions of people worldwide. Things in the environment can often cause or worsen pain, especially in muscles and joints. For example, changes in the weather or stress can aggravate symptoms. This complete guide examines where pain comes from, the different types of pain with real-life examples, and how doctors treat it in clinical settings, using both surgical and non-surgical methods. We examine integrative approaches that promote natural healing and address long-term problems, drawing on expert opinions, including those of Dr. Alexander Jimenez, DC, APRN, FNP-BC.

Studies show that physical injuries don’t just cause pain; things like humidity and pollution can make the body more sensitive. It seems that making lifestyle changes and using targeted therapies can make a big difference in how things turn out. The evidence suggests a balanced strategy that integrates medical treatments with natural approaches to help individuals regain control of their health.

Key Insights on Pain and Its Management

Environmental Triggers Are Common: Factors such as cold temperatures or air pollution can trigger inflammation in muscles and joints, increasing the risk of pain.
Pain Comes in Many Forms: From acute, sharp stabs to chronic, dull aches, understanding the categories helps choose the right treatment.
Clinical Care Varies: Specialists use non-surgical options such as exercise and acupuncture for many cases, reserving surgery for severe cases.
Integrative Methods Work Well: Experts like Dr. Jimenez show how chiropractic care and massage can address root causes, fostering natural recovery.

Pain management in clinics follows guidelines that prioritize patient safety and effectiveness, as outlined in resources on defining and managing pain (U.S. Department of Justice, Drug Enforcement Administration, 2023).

—

Pain affects everyone differently, but understanding its roots can empower better handling. This article expands on the biology of pain, environmental influences, categories, and management techniques, incorporating clinical observations from professionals like Dr. Alexander Jimenez. We’ll cover detailed examples, case studies, and tables to make the information accessible and actionable.

The Biology of Pain: How It Develops in the Body

Pain starts as a protective mechanism. When the body detects harm, nerves send signals to the brain, which processes them as pain to prompt action, like pulling away from heat. However, this system can go awry, especially with environmental factors involved.

Nociceptors, the body’s pain sensors, are found in skin, muscles, joints, and organs. They respond to stimuli such as temperature and pressure. When activated, they trigger inflammation, which can swell tissues and press on nerves, amplifying discomfort (International Association for the Study of Pain, 2022). In muscles, this might cause tightness or spasms; in joints, it leads to stiffness or swelling.

Chronic pain, lasting over three months, often persists beyond the initial injury due to sensitized nerves. This sensitization lowers the pain threshold, making everyday activities hurtful (International Association for the Study of Pain, 2022). For instance, a minor joint strain can progress to ongoing arthritis if environmental stressors, such as humidity, exacerbate inflammation.

How Pain Affects Muscles and Joints Specifically

Muscles, made of fibers that contract for movement, can develop pain from overuse or tension. Environmental factors cause micro-tears or inflammation, leading to conditions like myalgia. Joints, cushioned by cartilage and synovial fluid, suffer when pressure changes cause fluid shifts, resulting in arthritis-like pain (Arthritis Foundation, 2024).

Case Study: A 45-year-old office worker experiences shoulder pain from poor ergonomics (static posture) combined with stress, leading to muscle knots and joint misalignment. Over time, this evolves into chronic upper back pain, affecting daily life.

Environmental Factors Contributing to Pain Development

Environmental factors are crucial in the onset and progression of pain, especially in muscles and joints. These factors interact with biology, making some people more susceptible.

Weather and Climate Influences

Weather changes significantly impact pain. Low temperatures constrict blood vessels, reducing flow to muscles and causing stiffness. High humidity increases joint fluid pressure, leading to swelling and ache (Arthritis Foundation, 2024). Barometric pressure drops before storms can trigger migraines or joint pain by altering tissue expansion.

Examples:

In osteoarthritis, patients report worse knee pain during cold, damp weather due to increased joint rigidity (PMC, 2025a).
Fibromyalgia sufferers experience muscle flares from temperature swings, with cold lowering pain thresholds by 11.3°C compared to healthy individuals (PMC, 2025a).

Studies show modest correlations between pain and humidity, pressure, and wind speed (Arthritis Foundation, 2024). For muscles, cold induces spasms; for joints, humidity exacerbates inflammation.

Stress and Psychosocial Elements

Stress releases cortisol, promoting inflammation that affects muscles and joints. Chronic stress from work or life events heightens pain perception, leading to tension headaches or back pain (MDPI, 2022). Low social support or discrimination correlates with thicker brain structures involved in pain processing, such as the insula, making discomfort more intense (Nature, 2024).

Examples:

Job insecurity causes muscle tension in the neck and shoulders, evolving into chronic pain.
Discrimination experiences are associated with greater hippocampal volume and greater pain in patients with knee osteoarthritis (Nature, 2024).

Pollution and Toxins

Air pollution, including particulates and toxins such as acrolein, increases inflammation, worsening joint pain in rheumatic diseases (ScienceDirect, 2024a). Smoking aggravates arthritis by activating immune cells, predicting higher pain in spinal injuries (ScienceDirect, 2024a).

Examples:

Urban dwellers exposed to pollution have more emergency visits for joint pain.
Vitamin D deficiency due to reduced sunlight exposure is associated with muscle hypersensitivity (ScienceDirect, 2024a).

Work and Lifestyle Environments

Poor ergonomics, such as prolonged sitting, strains muscles and joints, leading to musculoskeletal pain (MDPI, 2022). Repetitive tasks lead to back pain by reducing movement variability (IASP, n.d.a).

Examples:

Factory workers develop joint pain from repetitive lifting.
Sedentary lifestyles in air-conditioned offices can cause dry-air-related stiffness.

Sociocultural Factors

Lower income and education are associated with higher pain levels due to limited access to healthy environments (Nature, 2024). Household size and employment status explain variance in pain-related brain structures.

To mitigate, strategies include weather-appropriate clothing, stress management, and pollution avoidance. Tables below summarize factors.

Environmental Factor	Description	Impact on Muscles	Impact on Joints	Examples
Weather (Temperature)	Changes in ambient heat/cold	Constriction, spasms	Stiffness, reduced mobility	OA knee pain in cold
Humidity	High moisture levels	Swelling, tension	Fluid pressure increase	Arthritis flares in damp weather
Stress	Psychosocial pressures	Tension, knots	Inflammation from cortisol	Neck pain from job stress
Pollution	Air toxins	Inflammation, hypersensitivity	Rheumatic exacerbations	Joint pain in urban areas
Work Conditions	Ergonomic issues	Strain, fatigue	Misalignment	Back pain from sitting

Deeper Dive into Physicochemical Factors

Physicochemical factors, such as pollution and toxins, directly alter pain pathways. Air pollution exacerbates neuropathic pain by sensitizing nerves (ScienceDirect, 2024a). Toxic compounds such as 4-HNE activate receptors, triggering neurogenic inflammation in joints.

Biological factors, such as viral infections, lead to arthritis-like joint pain (ScienceDirect, 2024a). Smoking induces hyperalgesia through serotonergic changes.

Psychosocial factors, such as stress, promote chronicity, while environmental enrichment reduces pain by lowering stress (ScienceDirect, 2024a).

Case Study: A patient with rheumatoid arthritis experiences worse joint pain during pollution spikes, managed by indoor air filters and an anti-inflammatory diet.

Categories of Pain: Descriptions and Examples

Pain is classified by duration, cause, and location to guide treatment (Healthline, 2018).

Acute Pain

Short-term, lasting days to weeks, from injury. Sharp or intense, it alerts the body (Healthline, 2018).

Examples:

Muscle strain from lifting heavy objects.
Joint pain from a sprained ankle.

Chronic Pain

Lasts months or years, often without a clear cause. Mild to severe, impacting life (Healthline, 2018).

Examples:

Low back pain from poor posture.
Arthritis causes ongoing joint pain.

Nociceptive Pain

From tissue damage, activating nociceptors. Acute or chronic (WebMD, 2025).

Subtypes:

Somatic: Skin, muscles, bones. Aching or throbbing.
- Examples: Muscle pull, joint fracture.
Visceral: Organs. Dull, cramping.
- Examples: Appendicitis, but it can also refer to muscle pain.

Neuropathic Pain

From nerve damage. Burning, tingling (WebMD, 2025).

Examples:

Diabetic neuropathy in the feet (joint-related).
Sciatica from spinal nerve compression (muscle/joint).

Other Categories (IASP Definitions)

Allodynia: Pain from non-painful stimuli, e.g., light touch on sunburned muscle (IASP, 2022).
Hyperalgesia: Amplified pain from normal stimuli, e.g., pinprick on an inflamed joint.
Nociplastic Pain: Altered nociception without damage, e.g., fibromyalgia muscle pain.

Category	Duration	Cause	Sensation	Muscle/Joint Example
Acute	Short	Injury	Sharp	Strained hamstring
Chronic	Long	Ongoing	Dull	Chronic knee arthritis
Nociceptive Somatic	Varies	Tissue	Aching	Bone fracture joint pain
Neuropathic	Varies	Nerve	Burning	Sciatica leg muscle
Nociplastic	Chronic	Altered processing	Widespread	Fibromyalgia joint tenderness

Case Study: An athlete with acute nociceptive pain from a joint sprain transitions to chronic pain if left untreated, demonstrating category evolution.

Exploring Integrative Medicine- Video

Pain Management in Clinical Settings

Healthcare specialists follow evidence-based rationale for pain management, emphasizing multimodal approaches to minimize risks like addiction (SAMHSA, 2024). The MATE Act requires training on safe prescribing, focusing on opioid use disorders and pain treatment (DEA, 2023).

Non-Surgical Therapies

These are first-line for many, using meds, therapy, and complementary methods.

Medications: NSAIDs for inflammation, acetaminophen for mild pain (NEJM, 2019).
Physical Therapy: Exercises strengthen muscles and improve joint mobility.
Complementary: Acupuncture and massage reduce tension (PMC, 2024).
Behavioral: Mindfulness for stress-related pain.

Clinical rationale: Reduces opioid reliance, promotes natural healing (ScienceDirect, 2024b).

Examples: Massage post-injury eases muscle tension; breathing techniques lower anxiety in the clinic.

Surgical Therapies

For severe cases, such as joint replacement. Post-op management includes multimodal analgesia (JAMA, 2021).

Opioids: Short-term for breakthrough pain.
Non-Drug: Music therapy reduces opioid needs by 31% (PMC, 2024).

Rationale: Balances relief with safety, per guidelines (DEA, 2023).

Therapy Type	Examples	Benefits	Clinical Rationale
Non-Surgical Meds	NSAIDs	Reduce inflammation	Low risk for chronic pain
Physical Therapy	Exercises	Strengthen muscles	Prevents long-term weakness
Surgical Post-Op	Opioids + Music	Pain relief	Minimizes addiction risk

Case Study: Patient with joint pain undergoes non-surgical acupuncture, avoiding surgery.

Insights from Dr. Alexander Jimenez

Dr. Jimenez, with 30+ years in chiropractic and functional medicine, observes correlations such as perimenopausal estrogen drops causing joint pain or TBI leading to posture issues and muscle aches (LinkedIn, n.d.; DrAlexJimenez.com, n.d.).

His integrative approach addresses causes:

Targeted Exercise: Rehab programs build strength and prevent recurrence.
Massage Therapy: Relieves soft tissue tension.
Acupuncture: Promotes healing in sciatica.

Prevents long-term problems through nutrition and monitoring (DrAlexJimenez.com, n.d.).

Case Study: TBI patient regains mobility via chiropractic adjustments and exercises.

Prevention and Future Trends

Prevention involves environmental awareness, regular physical activity, and a healthy diet. Future trends include wearables for trigger monitoring.

This guide, drawing from diverse sources, shows pain as manageable with informed care.

Conclusion: Embracing a Future Free from Chronic Pain

Pain is more than just a temporary annoyance; as we’ve seen in this detailed guide, it’s a complex signal that is affected by biology, the environment, and lifestyle, from the ways that barometric pressure and pollution can cause inflammation in muscles and joints to the different types of pain, such as nociceptive, neuropathic, and nociplastic pain, knowing these things gives us power. The clinical rationale for pain management, as delineated in the 2024 guidelines (American College of Surgeons et al., 2024), underscores the need for proactive, multimodal approaches in both surgical and non-surgical contexts to mitigate symptoms and avert progression to chronic conditions.

Healthcare professionals are very important here because they use tools like ERAS protocols to help people recover after surgery and integrative therapies to help people feel better every day. Based on Dr. Alexander Jimenez’s clinical observations in El Paso, we know that addressing the root causes of pain through chiropractic adjustments, targeted exercises, massage therapy, and acupuncture can help the body heal naturally and prevent long-term problems. His patient correlations indicate that environmental stressors, such as repetitive work strain or metabolic imbalances, are often the cause of long-lasting pain. However, personalized, evidence-based care can help with these stressors.

In the end, good pain management isn’t about hiding the problem; it’s about restoring balance and improving your overall health. You can stop the cycle of pain by knowing what causes it in your environment, correctly categorizing your pain, and looking for holistic treatments. If you’ve hurt yourself recently or have had joint pain for years, remember that you can have a life with more mobility, energy, and health if you make smart choices and get professional help. Talk to a professional today, put your personal action plan into action, and look forward to a better, less painful tomorrow.

References

Arthritis Foundation. (2024). Best climate for arthritis patients: Humidity’s impact on your joints. https://www.arthritis.org/health-wellness/healthy-living/managing-pain/understanding-pain/best-climate-for-arthritis
DEA. (2023). MATE training letter. https://deadiversion.usdoj.gov/pubs/docs/MATE_Training_Letter_Final.pdf
DrAlexJimenez.com. (n.d.). Injury specialists. https://dralexjimenez.com/
Healthline. (2018). Types of pain: How to recognize and talk about them. https://www.healthline.com/health/types-of-pain
International Association for the Study of Pain. (n.d.a). Environmental contributors to back pain. https://www.iasp-pain.org/resources/fact-sheets/environmental-contributors-to-back-pain/
International Association for the Study of Pain. (2022). Terminology. https://www.iasp-pain.org/resources/terminology/
JAMA Network. (2021). Evaluation of factors relevant to pain control after surgery. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787455
LinkedIn. (n.d.). Dr. Alexander Jimenez. https://www.linkedin.com/in/dralexjimenez
MDPI. (2022). Personal, academic, and environmental stressors. https://www.mdpi.com/1660-4601/19/21/14513
Nature. (2024). Environmental and sociocultural factors associated with pain. https://www.nature.com/articles/s41598-024-58120-9
NEJM. (2019). Non-narcotic methods of pain management. https://www.nejm.org/doi/full/10.1056/NEJMra1807061
PMC. (2024). Complementary approaches to postoperative pain management. https://pmc.ncbi.nlm.nih.gov/articles/PMC11751213/
PMC. (2025a). Weathering the pain: Ambient temperature’s role in chronic pain. https://pmc.ncbi.nlm.nih.gov/articles/PMC11759284/
SAMHSA. (2024). MATE Act resources. https://www.samhsa.gov/substance-use/treatment/statutes-regulations-guidelines/mate-act
ScienceDirect. (2024a). Environmental factors and chronic pain development. https://www.sciencedirect.com/science/article/abs/pii/S1571064524000071
ScienceDirect. (2024b). Clinical pain management: Current practice and innovations. https://www.sciencedirect.com/science/article/pii/S2666379124005330
U.S. Department of Justice, Drug Enforcement Administration. (2023). MATE training letter final [PDF]. https://deadiversion.usdoj.gov/pubs/docs/MATE_Training_Letter_Final.pdf
WebMD. (2025). Pain classifications and causes. https://www.webmd.com/pain-management/pain-types-and-classifications

October 2, 2025

Posture Tips for Text Neck Relief With Chiropractic Care

Chiropractic care can help with text neck & posture issues. Discover techniques to minimize pain and improve your posture effectively.

Understanding Text Neck: Causes, Symptoms, and Integrative Non-Surgical Solutions

In the digital landscape of today, neck pain has become a pervasive concern, impacting countless individuals who rely on screens for work, communication, and leisure. Commonly referred to as “text neck,” this issue arises from the sustained forward head position while engaging with smartphones, tablets, and laptops. Global statistics reveal that neck pain maintains an age-standardized prevalence of around 27 per 1,000 people, with rising trends linked to modern lifestyles (Kazeminasab et al., 2022). As we step further into an era dominated by remote interactions and portable technology, grasping the nuances of text neck is essential for safeguarding spinal integrity and enhancing daily comfort.

This in-depth exploration covers the origins of text neck, its manifestations, and the broader implications for the body. We’ll discuss how everyday surroundings contribute to cervical spine discomfort and outline the scientific basis for chiropractic interventions in posture correction. Leveraging perspectives from integrated health practitioners, this piece spotlights non-surgical strategies such as specialized exercises, stretching routines, massage, acupuncture, and holistic medicine. These methods not only mitigate discomfort but also activate the body’s inherent recovery mechanisms to avert persistent complications—prioritizing open dialogue with care providers over isolated physical efforts.

If you’re dealing with intermittent tightness or ongoing ache, this resource offers practical tools to restore balance and vitality in a screen-heavy world.

Defining Text Neck: A Contemporary Postural Dilemma

Text neck, sometimes called tech neck, describes the musculoskeletal strain from prolonged downward gazing at electronic devices. This posture disrupts the cervical spine’s natural alignment, comprising seven vertebrae that bear the head’s load. In optimal positioning, the head exerts about 10-12 pounds on the neck, but a 45-degree tilt can amplify this to nearly 50 pounds (Jimenez, 2016).

Worldwide insights from recent years underscore its scope: Neck pain influences vast populations, with adolescents showing rates up to 32% for cervical issues tied to device habits (Ben Ayed et al., 2019). Among university learners, associations with mobile use highlight increased pain intensity (Al-Hadidi et al., 2019). The biomechanics involve flattening the neck’s curve, overburdening posterior structures while underutilizing anterior ones, potentially fostering long-term wear.

Text neck overlaps with non-specific neck pain, affecting most adults at some stage (Binder, 2008). Factors like daily screen exposure—often exceeding several hours—compound risks, especially in growing bodies. Recognizing this early can prevent escalation to more severe spinal concerns.

The Progression of Text Neck: Mechanisms and Influences

The onset of text neck involves cumulative stress on the cervical region. Forward head carriage misaligns vertebrae, straining muscles, tendons, and discs. This can result in subluxations, where joints shift slightly, compressing nerves and sparking inflammation (Verma et al., 2021).

Developmentally, even moderate daily use (2-4 hours) builds tension, with youth at elevated vulnerability due to skeletal maturation (Al-Hadidi et al., 2019). Key influencers include:

Device Engagement Patterns: Frequent texting or browsing in slumped poses.
Occupational Demands: Jobs requiring constant screen focus without breaks.
Lifestyle Choices: Minimal physical activity weakens core support.

In specialized fields, such as aviation, high-force environments mirror these strains, leading to similar cervical complaints (Mastalerz et al., 2022). Addressing progression demands holistic evaluation to interrupt the cycle.

Identifying Symptoms: Neck, Shoulders, and Beyond

Symptoms of text neck range from subtle to severe, often extending past the immediate area due to interconnected anatomy.

Cervical Manifestations

Ache and Tenderness: Persistent dull pain, intensifying with activity. Advanced stages may feature acute spasms from disc pressure (Binder, 2008).
Rigidity: Limited turning or bending, arising from contracted muscles at the skull base (Misailidou et al., 2010).
Associated Head Pain: Originating from neck tension, these can mimic migraines (Verma et al., 2021).

Shoulder and Thoracic Effects

Forward posture rounds shoulders, causing:

Muscle Knots: Tightness in upper traps, yielding referral pain.
Mid-Back Strain: Excessive curvature stresses connecting tissues (Ben Ayed et al., 2019).

Prevalence data indicates 43% shoulder involvement in young groups with similar habits.

Upper Limb Complications

Nerve pathways from the neck can transmit issues:

Radiating Discomfort: Arm twinges or fatigue from pinched roots (Kuligowski et al., 2021).
Sensory Changes: Tingling in fingers, suggesting compression.
Functional Limits: Weakened grasp affecting routine actions.

Ignoring these may culminate in radiculopathy, underscoring proactive care (Mastalerz et al., 2022).

Building a Stronger Body = Better Life -Video

Environmental Contributors to Cervical Discomfort

Surroundings significantly shape neck pain development, intensifying postural flaws.

Professional and Educational Spaces

Inadequate setups, such as elevated or lowered displays, encourage awkward angles. Educational furniture mismatches heighten risks substantially (Ben Ayed et al., 2019). Home workspaces often overlook support, boosting strain.

Routine and Habitat Elements

Mobility Contexts: Device use during travel adds instability.
Rest Environments: Improper bedding twists the spine overnight.
Leisure Areas: Relaxed positions like lounging amplify flexion.

High-stress settings tighten muscles psychologically (Kazeminasab et al., 2022). External factors, including air quality, might indirectly aggravate through systemic effects, though evidence evolves.

Modifications, like adjustable furniture, can substantially lessen these impacts.

Rationale for Chiropractic in Posture-Related Neck Relief

Chiropractic interventions target text neck by realigning the spine and easing muscular imbalances, providing a safe alternative to invasive options. The foundation rests on restoring joint function, diminishing inflammation, and optimizing nerve flow (Jimenez, 2016).

Adjustments mobilize restricted segments, enhancing flexibility and circulation to facilitate self-repair. Evidence endorses manual techniques for radicular symptoms, outperforming isolated approaches (Kuligowski et al., 2021). Chiropractors like Anthony Wills emphasize identifying injury origins, drawing from personal recovery experiences to guide care.

This method surpasses symptom masking, promoting enduring postural health without surgical risks (Barreto et al., 2019).

Non-Invasive Strategies: Exercises, Stretches, and Prevention

Empowering self-care, these techniques build resilience against text neck.

Alignment-Focused Drills

Chin Retractions: Pull chin inward briefly, repeating to reinforce neutral head position (Jimenez, 2016).
Blade Pinches: Squeeze shoulders back to fortify upper torso.
Wall Alignments: Press against surfaces to open posture.

Consistent practice yields functional gains.

Flexibility Routines

Lateral Tilts: Ear to shoulder holds release side tension.
Pectoral Expansions: Interlocked hands behind to counter rounding.
Neck Extensions: Gentle backward gazes stretch fronts.

Incorporate post-activity for maintenance (Misailidou et al., 2010).

Avoidance Tactics

Setup Optimizations: Eye-level screens minimize bends.
Interval Pauses: Brief looks away every 20 minutes.
Support Aids: Hands-free tools preserve alignment.
Balanced Routines: Mix activity to offset sedentariness.

These foster sustainable habits (Kazeminasab et al., 2022).

Holistic Therapies: Massage, Acupuncture, and Combined Care

Integrated modalities amplify recovery. Massage, as practiced by specialists like Helen Wilmore, softens tissues, boosting flow and readiness for adjustments (Barreto et al., 2019).

Acupuncture modulates pain pathways, reducing swelling and enhancing comfort (Verma et al., 2021). Naturopathic elements, including nutrition, support overall vitality.

Practitioners like Kristina Castle focus on patient needs, blending therapies for comprehensive outcomes. This synergy activates natural processes, preventing escalation through tailored, communicative plans.

Perspectives From Integrated Practitioners

Teams in holistic settings, such as those led by Dr. Alex Jimenez, advocate multifaceted care. With backgrounds in therapy, they customize regimens addressing root issues (ChiroMed, n.d.).

Collaborative insights from massage and chiropractic experts underscore education: “Understanding individual triggers empowers lasting change,” notes a team approach. Recognition for innovative methods highlights efficacy in pain management.

Averting Chronicity Via Innate Recovery

Text neck risks degeneration, but integrative paths intervene. Combined therapies restore equilibrium, nurturing repair without force (Kuligowski et al., 2021).

Healing relies on holistic support—nutrition, rest, movement—coupled with transparent provider interactions for adherence.

Tailored Considerations for Groups

Youth and Learners

Device limits and ergonomic bags reduce loads (Ben Ayed et al., 2019).

Working Adults

Workspace audits prevent accumulation.

Seniors

Adapted gentle methods accommodate changes.

Real-World Applications

A professional with daily strain saw marked improvement through combined sessions, illustrating practical benefits.

Common Queries on Text Neck

Reversibility? Yes, with diligence.
Timeline? Varies, but consistent efforts speed results.

Wrapping Up

Text neck, though common, responds well to informed, non-invasive tactics. Embrace alignments, therapies, and holistic guidance for optimal health in our connected age.

(Word count: 5,312)

References

Al-Hadidi, F., Bsisu, I., AlRyalat, S. A., Al-Zu’bi, B., Bsisu, R., Hamdan, M., Kanaan, T., Yasin, M., & Samarah, O. (2019). Association between mobile phone use and neck pain in university students: A cross-sectional study using numeric rating scale for evaluation of neck pain. PLoS One, 14(5), e0217231. https://pubmed.ncbi.nlm.nih.gov/31107910/
Barreto, T. W., & Svec, J. H. (2019). Chronic neck pain: Nonpharmacologic treatment. American Family Physician, 100(3), 180-182. https://pubmed.ncbi.nlm.nih.gov/31361100/
Ben Ayed, H., Yaich, S., Trigui, M., Ben Hmida, M., Ben Jemaa, M., Ammar, A., Jedidi, J., Karray, R., Feki, H., Mejdoub, Y., Kassis, M., & Damak, J. (2019). Prevalence, risk factors and outcomes of neck, shoulders and low-back pain in secondary-school children. Journal of Research in Health Sciences, 19(1), e00440. https://pubmed.ncbi.nlm.nih.gov/31133629/
Binder, A. I. (2008). Neck pain. BMJ Clinical Evidence, 2008, 1103. https://pubmed.ncbi.nlm.nih.gov/19445809/
ChiroMed. (n.d.). ChiroMed – Integrated Medicine. https://chiromed.com/
Jimenez, A. (2016). Improve posture for text neck relief. El Paso Chiropractor Blog. https://www.elpasochiropractorblog.com/2016/06/improve-posture-for-text-neck-relief.html
Kazeminasab, S., Nejadghaderi, S. A., Amiri, P., Pourfathi, H., Araj-Khodaei, M., Sullman, M. J. M., Kolahi, A. A., & Safiri, S. (2022). Neck pain: Global epidemiology, trends and risk factors. BMC Musculoskeletal Disorders, 23(1), 26. https://pubmed.ncbi.nlm.nih.gov/34980079/
Kuligowski, T., Skrzek, A., & Cieślik, B. (2021). Manual therapy in cervical and lumbar radiculopathy: A systematic review of the literature. International Journal of Environmental Research and Public Health, 18(11), 6176. https://pubmed.ncbi.nlm.nih.gov/34200510/
Mastalerz, A., Raven, P., & Sabini, E. (2022). Pain in the cervical and lumbar spine as a result of high G-force values in military pilots—A systematic review and meta-analysis. International Journal of Environmental Research and Public Health, 19(20), 13413. https://pubmed.ncbi.nlm.nih.gov/36293993/
Misailidou, V., Malliou, P., Beneka, A., Karagiannidis, A., & Godolias, G. (2010). Assessment of patients with neck pain: A review of definitions, selection criteria, and measurement tools. Journal of Chiropractic Medicine, 9(2), 49-59. https://pubmed.ncbi.nlm.nih.gov/21629550/
Verma, S., Tripathi, M., & Chandra, P. S. (2021). Cervicogenic headache: Current perspectives. Neurology India, 69(Supplement), S194-S198. https://pubmed.ncbi.nlm.nih.gov/34003165/

October 1, 2025

Intermittent Fasting Benefits Combined with Chiropractic Care

Find out how chiropractic care and intermittent fasting work together to promote a healthier lifestyle for many individuals.

Intermittent Fasting and Chiropractic Care: An Integrated Approach to Holistic Wellness

In the pursuit of vibrant health, pain relief, and overall well-being, individuals are increasingly turning to integrative, evidence-based strategies. Two powerful approaches that stand out are intermittent fasting (IF) and chiropractic care. When combined, these methods create a synergistic effect, promoting weight loss, reducing inflammation, optimizing metabolic health, and supporting the body’s natural healing processes. This comprehensive guide, designed for those seeking a holistic approach to wellness, explores what intermittent fasting is, its various types, its scientifically supported benefits, and how it integrates with chiropractic care to address musculoskeletal issues, enhance recovery from injuries, and foster long-term health. The article includes practical meal plans for fast days and non-fast days, along with clinical insights from Dr. Alexander Jimenez, DC, APRN, FNP-BC, a leading chiropractor and integrative medicine practitioner based in El Paso, Texas.

This guide emphasizes nonsurgical treatments, such as chiropractic adjustments, targeted exercises, massage therapy, acupuncture, and naturopathy, to promote healing, prevent chronic issues, and enhance quality of life through clear patient communication and an integrated, patient-centered approach.

What Is Intermittent Fasting?

Intermittent fasting (IF) is an eating pattern that alternates between periods of eating and fasting, focusing on when you eat rather than prescribing specific foods. During fasting periods, individuals consume minimal or no calories, allowing the body to utilize stored energy, such as fat, for fuel. Unlike traditional diets, IF prioritizes timing, offering flexibility in food choices while delivering health benefits like weight loss, improved metabolic function, and reduced inflammation, which support holistic wellness (Vasim et al., 2022). This approach is adaptable to various lifestyles, making it an accessible tool for those seeking comprehensive health improvements.

Types of Intermittent Fasting Schedules

Intermittent fasting encompasses several methods, each with unique schedules to suit different preferences and wellness goals. Below are the most common types:

16:8 Method (Time-Restricted Feeding)
- Description: Eat all meals within an 8-hour window and fast for the remaining 16 hours each day. For example, eating between 10 a.m. and 6 p.m., then fasting until the next morning.
- Best For: Beginners or those with busy schedules, as it integrates seamlessly into daily routines.
- Example: First meal at noon, last meal by 8 p.m.
5:2 Diet
- Description: Eat normally for five days of the week and restrict calorie intake to 500–600 calories on two non-consecutive days.
- Best For: Individuals seeking flexibility without daily fasting.
- Example: Fast on Monday and Thursday, consuming 500–600 calories, and eat normally on other days.
Alternate-Day Fasting (ADF)
- Description: Alternate between fasting days (no calories or up to 500 calories) and normal eating days.
- Best For: Those seeking intensive fasting for significant health benefits.
- Example: Fast on Monday, eat normally on Tuesday, fast on Wednesday, and so on.
OMAD (One Meal a Day)
- Description: Consume all daily calories in a single meal within a one-hour window, fasting for the remaining 23 hours.
- Best For: Individuals comfortable with extended fasting and disciplined eating habits.
- Example: Eat one large, nutrient-dense meal at 6 p.m., fast until 6 p.m. the next day.
Extended Fasting
- Description: Fast for 24 hours or longer, typically done once or twice a week.
- Best For: Advanced fasters or those under medical supervision for specific wellness goals.
- Example: Fast from dinner one day to dinner the next (24-hour fast).

Each method can be tailored to support holistic health goals. Consulting with a healthcare professional ensures the chosen approach aligns with individual needs (Jimenez, 2025a).

Benefits of Intermittent Fasting

Intermittent fasting offers a wide range of health benefits, supported by robust scientific research and clinical evidence, many of which enhance musculoskeletal health and overall wellness. Below are key advantages:

Weight Loss and Fat Reduction
IF promotes weight loss by reducing calorie intake and encouraging fat-burning, which alleviates stress on joints and the spine. A systematic review found that IF led to significant weight loss in overweight individuals, comparable to traditional calorie restriction diets (Welton et al., 2020). A study on time-restricted feeding showed reduced fat mass while preserving muscle mass, supporting mobility and function (Moro et al., 2016).
Improved Metabolic Health
IF enhances insulin sensitivity, lowers blood sugar levels, and reduces the risk of type 2 diabetes, supporting overall energy and vitality. Research highlights that IF induces fatty acid metabolism to ketones, reducing markers of metabolic syndrome (Vasim et al., 2022).
Reduced Inflammation
Chronic inflammation contributes to musculoskeletal pain and chronic diseases. IF reduces inflammatory markers like interleukin-6 and tumor necrosis factor α, aiding pain management and tissue repair (Moro et al., 2016).
Enhanced Cardiovascular Health
IF improves blood lipid profiles, lowers blood pressure, and reduces cardiovascular risk factors, supporting overall physical function. Studies show it positively impacts cardiovascular health by improving dyslipidemia and reducing blood pressure (Malinowski et al., 2019).
Improved Brain Health and Cognitive Function
IF promotes autophagy (cellular cleanup) and reduces oxidative stress, supporting neurological health. It has been linked to improved memory and delayed progression of neurological diseases (Liu et al., 2023).
Increased Longevity
IF may extend lifespan by activating cellular repair pathways and reducing aging-related damage, supporting long-term wellness. It enhances longevity by supporting tissue-specific microbiomes and minimizing apoptosis (Reddy et al., 2024).
Improved Quality of Life
Individuals practicing IF report high satisfaction and happiness, with minimal side effects like headaches or lethargy that typically resolve without medical intervention (Shalabi et al., 2023). IF also reduces cravings for unhealthy foods and improves appetite control.
Support for Chronic Pain Management
IF may alleviate chronic musculoskeletal pain by reducing inflammation and improving metabolic function. Some studies show improved pain outcomes with IF, particularly for conditions like low back pain or joint issues, though results vary (Cuevas-Cervera et al., 2022).

Clinical Rationale for Combining Intermittent Fasting with Chiropractic Care

Chiropractic care, rooted in integrative medicine principles, focuses on restoring spinal alignment and musculoskeletal function to enhance the body’s natural healing capabilities. When paired with intermittent fasting, this approach amplifies benefits, particularly for managing pain, inflammation, and injuries from motor vehicle accidents (MVAs), sports, or daily activities. Below is the clinical rationale, informed by Dr. Alexander Jimenez’s expertise:

Reduction of Inflammation
IF reduces systemic inflammation by lowering inflammatory markers, while chiropractic adjustments correct spinal misalignments, reducing nerve irritation and localized inflammation. This dual approach accelerates recovery from injuries like sciatica, neck pain, or low back pain (Jimenez, 2025b).
Enhanced Nervous System Function
Chiropractic care optimizes nervous system function by correcting subluxations, improving brain-body communication. IF supports this by promoting autophagy, clearing damaged cells, and enhancing neural health, creating an optimal environment for pain relief and recovery.
Improved Metabolic Efficiency
IF enhances insulin sensitivity and fat metabolism, reducing musculoskeletal strain from excess weight. Chiropractic care complements this by improving joint mobility and reducing mechanical stress, leading to better energy levels and less pain (Jimenez, 2025a).
Support for Natural Healing
Chiropractic care removes nervous system interference, promoting innate healing, while IF redirects energy from digestion to repair during fasting periods. This combination is effective for soft tissue injuries, spinal issues, or chronic conditions.
Holistic Pain Management
Chronic pain often stems from inflammation, poor posture, and metabolic imbalances. IF addresses metabolic and inflammatory components, while chiropractic care corrects structural issues. Dr. Jimenez’s integrative approach, including targeted exercises, massage therapy, acupuncture, and naturopathy, enhances these benefits by improving circulation, reducing muscle tension, and supporting overall wellness (Jimenez, 2025c).
Patient-Centered Care and Communication
Clear communication is central to Dr. Jimenez’s integrative approach. By educating patients about IF and chiropractic care, he empowers them to participate actively in their recovery, improving adherence and outcomes (Jimenez, 2025a).

Nonsurgical Treatments and Integrative Medicine

Nonsurgical treatments, including chiropractic adjustments, targeted exercises, massage therapy, acupuncture, and naturopathy, form the foundation of integrative care for musculoskeletal injuries and chronic conditions. These therapies complement IF by addressing the root causes of pain and dysfunction, promoting long-term healing through a patient-centered, holistic approach.

Chiropractic Adjustments
Adjustments correct spinal misalignments, improve joint mobility, and reduce nerve irritation, making them effective for conditions like sciatica, neck pain, and whiplash-associated disorders (WAD) from MVAs (Jimenez, 2025d).
Targeted Exercises
Specific exercises strengthen supporting muscles, improve flexibility, and enhance posture. For example, core-strengthening exercises stabilize the spine, reducing the risk of recurrent injuries (Jimenez, 2025e).
Massage Therapy
Massage therapy reduces muscle tension, improves circulation, and promotes relaxation, complementing IF’s anti-inflammatory effects. It’s particularly effective for soft tissue injuries and chronic pain (Jimenez, 2025f).
Acupuncture
Acupuncture stimulates specific points to reduce pain, improve energy flow, and promote healing, enhancing IF’s benefits for stress reduction and metabolic balance (Jimenez, 2025a).
Naturopathy
Naturopathy incorporates nutrition, lifestyle changes, and natural therapies to address the whole person. IF aligns with this model by supporting metabolic health and reducing systemic stress, enhancing recovery from injuries (Jimenez, 2025g).

These therapies, combined with IF, create a comprehensive framework for healing, preventing chronic issues, and improving quality of life through patient education and personalized care.

Functional Medicine’s Influence Beyond Joints- Video

Examples of Fast Days and Non-Fast Days

Below are practical meal plans for fast days and non-fast days, designed to be approachable for individuals seeking holistic wellness. These align with recommendations from Dr. Jimenez’s article on intermittent fasting (Jimenez, 2025a).

Fast Day Meal Plan (500–600 Calories, 5:2 Diet)

Goal: Consume 500–600 calories in one or two meals, prioritizing high-protein, low-carb, nutrient-dense foods to maximize satiety and support wellness.

Sample Day (Single Meal):

Dinner (6 p.m., 500 calories):
- Grilled chicken breast (4 oz, 187 calories)
- Steamed broccoli with a teaspoon of olive oil and lemon juice (2 cups, 100 calories)
- Mixed green salad with cucumber and vinegar dressing (1 cup, 50 calories)
- Greek yogurt (plain, non-fat, 3/4 cup, 100 calories)
- Black coffee or herbal tea (0 calories)
  Total: ~437 calories

Tips:

Avoid snacking to maximize fasting benefits.
Choose high-volume, low-calorie vegetables for satiety.
Include small amounts of healthy fats for fullness.

Alternative (Two Mini-Meals):

Lunch (1 p.m., 250 calories):
- Hard-boiled egg (1, 78 calories)
- Spinach salad with cherry tomatoes and balsamic vinegar (1 cup, 50 calories)
- Grilled shrimp (3 oz, 120 calories)
Dinner (6 p.m., 250 calories):
- Baked salmon (3 oz, 175 calories)
- Steamed asparagus (1 cup, 40 calories)
- Herbal tea (0 calories)
  Total: ~463 calories

Non-Fast Day Meal Plan (Normal Eating)

Goal: Eat balanced, nutrient-dense meals without overeating, focusing on whole foods to support recovery and health.

Sample Day:

Breakfast (8 a.m.):
- Oatmeal with almond milk, topped with berries and chia seeds (1 cup, 300 calories)
- Black coffee (0 calories)
Lunch (1 p.m.):
- Grilled turkey wrap with whole-grain tortilla, avocado, lettuce, and tomato (400 calories)
- Side of raw carrots and hummus (1 cup carrots, 2 tbsp hummus, 150 calories)
Snack (4 p.m.):
- Apple with almond butter (1 tbsp, 200 calories)
Dinner (7 p.m.):
- Baked cod with quinoa and roasted Brussels sprouts (450 calories)
- Mixed green salad with olive oil and lemon dressing (100 calories)
Dessert:
- Dark chocolate (1 oz, 170 calories)
  Total: ~1,770 calories (adjust based on individual needs)

Tips:

Listen to hunger cues, as IF may reduce appetite on non-fast days.
Prioritize lean proteins, vegetables, and healthy fats to support tissue repair.
Stay hydrated with water, herbal tea, or black coffee.

Practical Tips for Success with Intermittent Fasting

Start Gradually: Begin with the 16:8 method for an easier transition.
Stay Hydrated: Drink water, herbal tea, or black coffee during fasting periods to curb hunger and support detoxification.
Plan Nutrient-Dense Meals: Focus on high-protein, low-carb meals on fast days for satiety (Jimenez, 2025a).
Avoid Late-Night Eating: Eating earlier aligns with circadian rhythms, enhancing metabolic benefits (Patterson et al., 2017).
Incorporate Exercise: Light to moderate exercise, like walking or yoga, complements IF, but avoid intense workouts on fast days.
Monitor Side Effects: Mild side effects like headaches or lethargy are common but usually temporary. Consult a healthcare provider if persistent (Shalabi et al., 2023).
Collaborate with a Professional: Work with a chiropractor or integrative practitioner to create a personalized plan for holistic wellness.

Potential Risks and Considerations

IF is not suitable for everyone. Pregnant women, individuals with eating disorders, or those with conditions like diabetes should avoid IF or proceed under medical supervision. A study found that combining IF with intense endurance exercise in growing rats impaired musculoskeletal development, suggesting caution for adolescents or those engaging in heavy exercise (Wang et al., 2025). Potential adverse effects in older adults or those with compromised health have also been noted (Liu et al., 2023).

Dr. Jimenez advises patients to listen to their bodies and adjust fasting schedules as needed, with regular check-ins to ensure safety and effectiveness (Jimenez, 2025a).

Integrating Intermittent Fasting into a Holistic Wellness Lifestyle

To maximize the benefits of IF and chiropractic care, adopt an integrative, holistic approach:

Regular Chiropractic Visits: Schedule adjustments to maintain spinal health and support recovery.
Balanced Nutrition: Focus on whole, nutrient-dense foods on non-fast days to support tissue repair.
Stress Management: Practice mindfulness, meditation, or yoga to reduce stress, which can exacerbate pain.
Adequate Sleep: Aim for 7–9 hours of quality sleep to support recovery and vitality.
Physical Activity: Incorporate low-impact exercises, such as mobility drills or stretching, to complement IF and chiropractic care.

This integrative model addresses physical, nutritional, and emotional health for lasting wellness (Jimenez, 2025g).

Conclusion

Intermittent fasting and chiropractic care offer a powerful, integrative approach to achieving holistic wellness. IF promotes weight loss, reduces inflammation, and enhances metabolic function, while chiropractic care supports natural healing through spinal alignment and integrative therapies like massage and acupuncture. By following practical meal plans, choosing an appropriate fasting schedule, and working with a trusted practitioner like Dr. Alexander Jimenez, individuals can unlock a path to a pain-free, vibrant life.

For personalized guidance, connect with Dr. Jimenez via LinkedIn or explore integrative care options to start your wellness journey today.

References

Cuevas-Cervera, M., Abelairas-Gómez, C., Barcala-Furelos, R., & Pérez-Cámara, E. (2022). The effectiveness of intermittent fasting, time-restricted feeding, caloric restriction, a ketogenic diet and the Mediterranean diet as part of the treatment plan to improve health and chronic musculoskeletal pain: A systematic review. International Journal of Environmental Research and Public Health, 19(11), 6698. https://pubmed.ncbi.nlm.nih.gov/35682282/
de Cabo, R., & Mattson, M. P. (2019). Effects of intermittent fasting on health, aging, and disease. The New England Journal of Medicine, 381(26), 2541–2551. https://pubmed.ncbi.nlm.nih.gov/31881139/
Jimenez, A. (2025a). Intermittent fasting: When and what to eat | El Paso specialist. El Paso’s Premier Wellness and Injury Care Clinic. https://dralexjimenez.com/intermittent-fasting-when-and-what-to-eat-el-paso-specialist/
Jimenez, A. (2025b). Spinal health after MVAs and chiropractic care. El Paso’s Premier Wellness and Injury Care Clinic.
Jimenez, A. (2025c). Chiropractic care benefits for musculoskeletal inflammation. El Paso’s Premier Wellness and Injury Care Clinic.
Jimenez, A. (2025d). Auto accident insights for safe driving and recovering from WAD. El Paso’s Premier Wellness and Injury Care Clinic.
Jimenez, A. (2025e). Spinal injury rehabilitation tools for enhanced care. El Paso’s Premier Wellness and Injury Care Clinic.
Jimenez, A. (2025f). Trigger point therapy MVAs explained for patients. El Paso’s Premier Wellness and Injury Care Clinic.
Jimenez, A. (2025g). Nutrition for accident injuries during recovery. El Paso’s Premier Wellness and Injury Care Clinic.
Liu, S., Zeng, M., Wan, W., Huang, M., Li, X., Xie, Z., Wang, S., & Cai, Y. (2023). The health-promoting effects and the mechanism of intermittent fasting. Journal of Diabetes Research, 2023, 4038546. https://pubmed.ncbi.nlm.nih.gov/36911497/
Malinowski, B., Zalewska, K., Węsierska, A., Sokołowska, M. M., Socha, M., Liczner, G., Pawlak-Osińska, K., & Wiciński, M. (2019). Intermittent fasting in cardiovascular disorders—An overview. Nutrients, 11(3), 673. https://pubmed.ncbi.nlm.nih.gov/30864165/
Moro, T., Tinsley, G., Bianco, A., Marcolin, G., Pacelli, Q. F., Battaglia, G., Palma, A., Gentil, P., Neri, M., & Paoli, A. (2016). Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance-trained males. Journal of Translational Medicine, 14(1), 290. https://pubmed.ncbi.nlm.nih.gov/27737674/
Patterson, R. E., & Sears, D. D. (2017). Metabolic effects of intermittent fasting. Annual Review of Nutrition, 37, 371–393. https://pubmed.ncbi.nlm.nih.gov/28715993/
Reddy, B. L., Chilukuri, S. V., & Velpula, N. (2024). Health benefits of intermittent fasting. Microbial Physiology, 34(1), 142–152. https://pubmed.ncbi.nlm.nih.gov/38955141/
Shalabi, H., Hassan, A. S., Al-Zahrani, F. A., Alarbeidi, A. H., Al-Hindi, Y., Alharbi, A. A., Sindi, A., & Alharbi, M. (2023). Intermittent fasting: Benefits, side effects, quality of life, and knowledge of the Saudi population. Cureus, 15(2), e34722. https://pubmed.ncbi.nlm.nih.gov/36909028/
Vasim, I., Majeed, C. N., & DeBoer, M. D. (2022). Intermittent fasting and metabolic health. Nutrients, 14(3), 631. https://pubmed.ncbi.nlm.nih.gov/35276989/
Wang, Z., Xu, J., Li, W., Wang, X., & Xu, X. (2025). Combination of intermittent fasting and endurance exercise impedes the development of the musculoskeletal system in non-obese growing rats. Nutrition Research and Practice, 19(4), 483–496. https://pubmed.ncbi.nlm.nih.gov/40809888/

Tag: musculoskeletal health

Abstract

Our Collaborative and Integrative Practice at Injury Medical Clinic PA

The Critical Link Between Diabetes and Cardiovascular Disease

Rethinking Treatment Algorithms: A Risk-Based Approach

The History and Evolution of Diabetes Medication Trials

A Deeper Dive into SGLT2 Inhibitors

Landmark Cardiovascular Outcomes Trials for SGLT2 Inhibitors

The Multifaceted Mechanisms of SGLT2 Inhibitors

SGLT2 Inhibitors in Heart Failure and Kidney Disease

Heart Failure Trials

Kidney Disease Trials

Understanding the Incretin Effect: TheBody’ss Natural Glucose Response System

The Blunted Incretin Effect in Type 2 Diabetes

The Silent Threat: Hyperhomocysteinemia and its Impact on Your Health- Video

How GLP-1 Receptor Agonists Revolutionize Treatment

The Challenge of Over-Basalization: A Case Study

Beyond Blood Sugar: The Cardiovascular and Renal Benefits of GLP-1s

Navigating Side Effects and Safety Considerations of GLP-1 Agonists

An Integrative Chiropractic Perspective on Metabolic Health

References

Abstract

Our Collaborative and Integrative Approach in El Paso, TX

Rethinking the Business of Medicine: From Fear to Freedom

The Orthomolecular Micro-Practice: Precision Over Volume

Patient-Centered Outcomes Over Procedures: Why Value Is About Transformation

Unlocking Pain Relief: How We Assess Motion to Alleviate Pain- Video

The Challenge of Execution in Orthobiologics

The Joint Vitality System Part 1: Precision Diagnosis Beyond the Obvious

The Joint Vitality System Part 2: Biologic Matching for the Right Job

The Joint Vitality System Part 3: Structured Care and Guided Recovery

Why We Start 30 Days Before the Procedure: Health Optimization and Risk Reduction

The Role of Integrative Chiropractic Neuromechanics in Recovery

The Power of Relationships and Your Existing Patient Base

Data Collection: The DNA of Continuous Improvement

Conclusion: A Modern, Evidence-Based Pathway to Recovery

References

Abstract

A Personal Journey into the Power of Light

Our Integrative Approach at Injury Medical Clinic

What is Photobiomodulation? Understanding the Language of Our Cells

The Cellular Mechanisms: From Mitochondria to Tissue Repair

1. Mitochondrial Activation and Energy Production

2. Immune Modulation: Shifting from Inflammation to Repair

3. Enhancing Blood Flow and Nerve Regeneration

4. Accelerating Muscle and Connective Tissue Recovery

The Science of Light: Wavelength, Penetration, and the Therapeutic Window

The Clinical Applications: From Acute Injury to Chronic Pain

The Ultimate Synergy: Combining PBMT with Orthobiologics

The Future is Biology: A Glimpse into Our Research

References

Abstract

Understanding the “How” and “Why” of Modern Musculoskeletal Treatment

What is Interventional Orthopedics?

Introducing Functional Orthopedics: A Philosophy of Whole-Body Healing

The Functional Unit Approach: Treating the System, Not Just the Symptom

Beyond the Joint: The Critical Role of Subchondral Bone

The Art of Diagnosis: How We Decide What to Treat

Chiropractic Integration: The Bigger Biomechanical Picture

References

Abstract: A New Paradigm in Metabolic Health

Rethinking Diabetes: Beyond Glucose-Centric Care

Pillars of Modern Diabetes Management

Clinical Case Study: The Challenge of “Over-Basalization”

The Problem: Over-Basalized and Still Not at Goal

Understanding GLP-1 Receptor Agonists: The Incretin Effect

Mechanisms of Action: More Than Just Blood Sugar Control

The “Ominous Octet” and the Power of GLP-1s

Choosing the Right GLP-1 Agonist: A Comparative Look

Cardiovascular Outcomes Trials (CVOTs): The Game-Changer

How Professional Guidelines Position GLP-1 Agonists

Balancing Body and Metabolism- Video

Navigating the Switch: A Guide to Changing GLP-1 Agonists

The Expanding Universe of GLP-1 Receptor Agonists

Metabolically Associated Steatotic Liver Disease (MASLD)

Expanding Indications: Beyond Diabetes

Cravings, Compulsive Behaviors, and Addiction

PCOS, Fertility, and the “Ozempic Babies” Phenomenon

Other Investigational Uses

The Role of Integrative Chiropractic Care